Co-Director, Wellstone Muscular Dystrophy Cooperative Research Center
Contact Information
Primary Office
5239B Roy Carver Pavilion
Iowa City, IA 52242
319-384-9084
Lab
4270A Carver Biomedical Research Building
Iowa City, IA 52242
319-335-8215
Education
BS, Purdue UniversityPhD, Anatomy, Indiana University
MD, Indiana University School of Medicine
Fellow, Neuropathology, University of Iowa College of Medicine
Licensure and Certifications
Anatomic Pathology - American Board of PathologyNeuropathology - American Board of Pathology
State of Iowa Medical License - Iowa Board of Medicine
Education/Training Program Affiliations
Department of Pathology Graduate Program, Interdisciplinary Graduate Program in NeuroscienceCenter, Program and Institute Affiliations
Center for Gene Therapy of Cystic Fibrosis and other Genetic Diseases, Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research CenterResearch Summary
Muscular dystrophies are a diverse group of inherited disorders characterized by progressive muscle weakness and wasting. Dr. Moore is involved in the evaluation of patient biopsies and in research partially funded through a center grant from NIH. This Paul D. Wellstone Muscular Dystrophy Cooperative Research Center is exploring therapeutic strategies for the treatment of various muscular dystrophies by enabling translational research on muscular dystrophies and providing advanced diagnostic services. The MDCRC is composed of two research projects, three cores and investigators with a proven track record of excellence and collaboration. The Center researchers' studies and facilities will explore basic biological mechanisms that relate to possible treatments for muscular dystrophies, facilitate translational research on muscular dystrophies and provide advanced diagnostic services to patients and clinical trial participants. The Director and Co-director, Kevin Campbell and Steven Moore, are investigators with established records in basic, translational, and clinical research on muscular dystrophy.Additional basic science collaboration with Dr. Kevin Campbell, Department of Molecular Physiology and Biophysics ( The Laboratory of Dr. Kevin P. Campbell) involves the pathologic characterization of genetic mouse models of muscular dystrophy. Many of these models use Cre-lox methodology to selectively knock out brain or peripheral nerve dystroglycan. These mice model congenital muscular dystrophy. A second basic science collaboration is with Lori Wallrath (Department of Biochemistry, The University of Iowa) studying lamin A/C.
Including the Wellstone MDCRC mentioned above, clinical diagnostic work in the general area of muscular dystophies has expanded into basic and clinical research projects in collaboration with several physicians at other institutions, Kevin Campbell, and Kathy Mathews (Department of Pediatrics, The University of Iowa). Current clinical studies involve: (1) a natural history study of patients with dystroglycanopathy, (2) a search for new genes in congenital myopathy and muscular dystrophy patients, (3) dysferlinopathy patients with amyloid deposition, (4) autophagic vacuolar myopathy patients, and (5) improvements in diagnostic testing.
Publications
Chandran, S., Suggs, J. A., Wang, B. J., Han, A., Bhide, S., Cryderman, D. E., Moore, S. A., Bernstein, S. I., Wallrath, L. L. & Melkani, G. C. (2018). Suppression of myopathic lamin mutations by muscle-specific activation of AMPK and modulation of downstream signaling. Human molecular genetics. PMID: 30239736.
Aeffner, F., Faelan, C., Moore, S. A., Moody, A., Black, J. C., Charleston, J. S., Frank, D. E., Dworzak, J., Piper, J. K., Ranjitkar, M., Wilson, K., Kanaly, S., Rudmann, D. G., Lange, H., Young, G. D. & Milici, A. J. (2018). Validation of a Muscle-Specific Tissue Image-Analysis Tool for Quantitative Assessment of Dystrophin Staining in Frozen Muscle Biopsies. Archives of pathology & laboratory medicine. PMID: 30168727.
Mul, K., Lemmers RJLF,, Kriek, M., van der Vliet, P. J., van den Boogaard, M. L., Badrising, U. A., Graham, Jr, J. M., Lin, A. E., Brand, H., Moore, S. A., Johnson, K., Evangelista, T., Töpf, A., Straub, V., Kapetanovic García, S., Sacconi, S., Tawil, R., Tapscott, S. J., Voermans, N. C., van Engelen BGM,, Horlings CGC,, Shaw, N. D. & van der Maarel, S. M. (2018). FSHD type 2 and Bosma arhinia microphthalmia syndrome: Two faces of the same mutation. Neurology. PMID: 29980640.
Larson, A. A., Baker, 2nd, P. R., Milev, M. P., Press, C. A., Sokol, R. J., Cox, M. O., Lekostaj, J. K., Stence, A. A., Bossler, A. D., Mueller, J. M., Prematilake, K., Tadjo, T. F., Williams, C. A., Sacher, M. & Moore, S. A. (2018). TRAPPC11 and GOSR2 mutations associate with hypoglycosylation of a-dystroglycan and muscular dystrophy. Skeletal muscle, 8(1), 17. PMID: 29855340.
Martinez-Thompson, J. M., Moore, S. A. & Liewluck, T. (2018). A novel CAPN3 mutation in late-onset limb-girdle muscular dystrophy with early respiratory insufficiency. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. PMID: 29685414.
Brun, B. N., Willer, T., Darbro, B. W., Gonorazky, H. D., Naumenko, S., Dowling, J. J., Campbell, K. P., Moore, S. A. & Mathews, K. D. (2018). Uniparental disomy unveils a novel recessive mutation in POMT2. Neuromuscular disorders : NMD. PMID: 29759639.
Xu, J., Xu, L., Lau, Y. S., Gao, Y., Moore, S. A. & Han, R. (2018). A novel ANO5 splicing variant in a LGMD2L patient leads to production of a truncated aggregation-prone Ano5 peptide. The journal of pathology. Clinical research, 4(2), 135-145. PMID: 29665321.
Carlson, C. R., Moore, S. A. & Mathews, K. D. (2018). Dystrophinopathy muscle biopsies in the genetic testing ERA: One center's data. Muscle & nerve. PMID: 29365344.
Conant, A., Curiel, J., Pizzino, A., Sabetrasekh, P., Murphy, J., Bloom, M., Evans, S. H., Helman, G., Taft, R. J., Simons, C., Whitehead, M. T., Moore, S. A. & Vanderver, A. (2018). Absence of Axoglial Paranodal Junctions in a Child With CNTNAP1 Mutations, Hypomyelination, and Arthrogryposis. Journal of child neurology, 883073818776157. PMID: 29882456.
Wilson, K., Faelan, C., Patterson-Kane, J. C., Rudmann, D. G., Moore, S. A., Frank, D., Charleston, J., Tinsley, J., Young, G. D. & Milici, A. J. (2017). Duchenne and Becker Muscular Dystrophies: A Review of Animal Models, Clinical End Points, and Biomarker Quantification. Toxicologic pathology, 45(7), 961-976. PMID: 28974147.
Donkervoort, S., Chan SHS,, Hayes, L. H., Bradley, N., Nguyen, D., Leach, M. E., Mohassel, P., Hu, Y., Thangarajh, M., Bharucha-Goebel, D., Kan, A., Ho RSL,, Reyes, C. A., Nance, J., Moore, S. A., Foley, A. R. & Bönnemann, C. G. (2017). Cytoplasmic body pathology in severe ACTA1-related myopathy in the absence of typical nemaline rods. Neuromuscular disorders : NMD. PMID: 28416349.
Shaw, N. D., Brand, H., Kupchinsky, Z. A., Bengani, H., Plummer, L., Jones, T. I., Erdin, S., Williamson, K. A., Rainger, J., Stortchevoi, A., Samocha, K., Currall, B. B., Dunican, D. S., Collins, R. L., Willer, J. R., Lek, A., Lek, M., Nassan, M., Pereira, S., Kammin, T., Lucente, D., Silva, A., Seabra, C. M., Chiang, C., An, Y., Ansari, M., Rainger, J. K., Joss, S., Smith, J. C., Lippincott, M. F., Singh, S. S., Patel, N., Jing, J. W., Law, J. R., Ferraro, N., Verloes, A., Rauch, A., Steindl, K., Zweier, M., Scheer, I., Sato, D., Okamoto, N., Jacobsen, C., Tryggestad, J., Chernausek, S., Schimmenti, L. A., Brasseur, B., Cesaretti, C., García-Ortiz, J. E., Buitrago, T. P., Silva, O. P., Hoffman, J. D., Mühlbauer, W., Ruprecht, K. W., Loeys, B. L., Shino, M., Kaindl, A. M., Cho, C. H., Morton, C. C., Meehan, R. R., van Heyningen, V., Liao, E. C., Balasubramanian, R., Hall, J. E., Seminara, S. B., Macarthur, D., Moore, S. A., Yoshiura, K. I., Gusella, J. F., Marsh, J. A., Graham, Jr, J. M., Lin, A. E., Katsanis, N., Jones, P. L., Crowley, Jr, W. F., Davis, E. E., FitzPatrick, D. R. & Talkowski, M. E. (2017). SMCHD1 mutations associated with a rare muscular dystrophy can also cause isolated arhinia and Bosma arhinia microphthalmia syndrome. Nature genetics, 49(2), 238-248. PMID: 28067909.
Quinn, C., Moore, S. A., Bardakjian, T. M. & Karam, C. (2016). Clinical Reasoning: A 30-year-old man with progressive weakness and atrophy. Neurology, 87(19), e227-e230. PMID: 27821570.
Lawlor, M. W., Beggs, A. H., Buj-Bello, A., Childers, M. K., Dowling, J. J., James, E. S., Meng, H., Moore, S. A., Prasad, S., Schoser, B. & Sewry, C. A. (2016). Skeletal Muscle Pathology in X-Linked Myotubular Myopathy: Review With Cross-Species Comparisons. pp. 102-110. J Neuropathol Exp Neurol. PMID: 26823526.
Jensen, B. S., Willer, T., Saade, D. N., Cox, M. O., Mozaffar, T., Scavina, M., Steffans, V. A., Winder, T. L., Campbell, K. P., Moore, S. A. & Mathews, K. D. (2015). Gmppb-Associated Dystroglycanopathy: Emerging Common Variants with Phenotype Correlation. Hum Mutat. PMID: 26310427.
Brennan, K. M., Bai, Y., Pisciotta, C., Wang, S., Feely, S. M., Hoegger, M., Gutman, L., Moore, S. A., Gonzalez, M., Sherman, D. L., Brophy, P. J., Zuchner, S. & Shy, M. E. (2015). Absence of Dystrophin Related Protein-2 disrupts Cajal bands in a patient with Charcot-Marie-Tooth disease. Neuromuscul Disord, 15, 659-8. PMID: 26227883.
Strickland, A. V., Schabbutl, M., Offenbacher, H., Synofzik, M., Hauser, N. A., Brunner-Krainz, M., Gruber-Sedlmayr, U. & Moore, S. (2015). Mutation screen reveals novel variants and expands the phenotypes associated with DYNC1H1. J Neurol.. PMID: 26100331.
Pisciotta, C., Bai, Y., Brennan, K. M., Wu, X., Grider, T., Feely, S., Wang, S., Moore, S., Siskind, C., Gonzales, M., Zuchner, S. & Shy, M. E. (2015). Reduced neurofilament expression in cutaneous nerve fibers of patients with CMT2E. Neurology. PMID: 26109717.
Dialynas, G., Shrestha, O. K., Ponce, J. M., Zwerger, M., Thiemann, D. A., Young, G. H., Moore, S. a., Yu, L., Lammerding, J. & Wallrath, L. L. (2015). Myopathic Lamin Mutations Cause Reductive Stress and Activate the Nrf2/Keap-1 Pathway. PloS Genet, 11(5). PMID: 25996830.
Jerath, N. U., Crockett, C. D., Moore, S. A., Shy, M. E., Weihl, C. C., Chou, T. F., Grider, T., Gonzalez, M. A., Zuckner, S. & Swenson, A. (2015). Rare manifestation of a c.290C>T, p.Gly97Glu VCP mutation. Case Reports Genet, 2015. PMID: 25878907.
Bharucha-Goebel, D. X., Neil, E., Donkervoort, S., Dastgir, J., Wiggs, E. A., Winder, T. L., Moore, S. A., Iannaccone, S. & Bonnemann, C. G. (2015). Intrafamilial variability in GMPPB associated dystroglycanopathy: broadening the clinical phenotype. Neurology. PMID: 25770200.
Crockett, C. D., Bertrand, L. A., Cooper, C. S., Rahhal, R. M., Liu, K., Zimmerman, M. B., Moore, S. A. & Mathews, K. D. (2015). Urologic and gastrointestinal symptoms in the dystroglycanopathies. Neurology. PMID: 25568299.
Tsuda, T., Fitzgerald, K., Scavena, m., Gidding, S., Cox, M. O., Marks, H., Flanigan, K. M. & Moore, S. A. (2015). Early-progressive dilated cardiomyopathy in a family with Becker muscular dystrophy related to a novel frameshift mutation in the dystrophin gene exon 27. (Vols. 60). pp. 151-155. J Hum Genet. PMID: 25537791.
Sanmaneechai, O., Swenson, A., Gerke, A. K., Moore, S. A. & Shy, M. E. (2015). Inclusion body myositis with sarcoidosis: A case report. Neuromuscul Disord, 25, 297-300. PMID: 25599912.
Al-Zaidy, S. A., Malik, V., Kneile, K., Rosales, X. Q., Gomez, A. M., Lewis, S., Gastier-Foster, J., Kang, P., Darras, B., Kunkel, L., Carlo, J., SAhenk, Z., Moore, S. A., Pyatt, R. & Mendell, J. R. (2015). Slowly progressive limb-girdle muscular dystrophy type 2C associated with founder mutation in the SGCG gene in Puerto Rican Hispanics. Mol Genet Genomic Med, 3, 92-98. PMID: 25802879.
Dowling, J. J., Moore, S. A., Kalimo, H. & Minassian, B. (2015). X-linked autophagic vacuolar myopathy: a failure of self eating. Acta Neuropathol, 129, 383-390. PMID: 25644398.
Inamori, K. I., Willer, T., Hara, Y., Venzke, D., Anderson, M. E., Clarke, N. F., Guicheney, P., Bönnemann, C. G., Moore, S. A. & Campbell, K. P. (2014). Endogenous glucuoronyltransferase activity of LARGE and LARGE2 required for functional modification of a-dystroglycan in cells and tissues. (Vols. 289). (41), pp. 138-48. J Biol Chem. PMID: 25138275.
Bushby, K., Finkel, R., Wong, B., Barohn, R., Campbell, C., Comi, G. P., Connolly, A. M., Day, J. W., Flanigan, K. M., Goemans, N., Jones, K. J., Mercuri, E., Quinlivan, R., Renfroe, J. B., Russman, B., Ryan, M. M., Tulinius, M., Voit, T., Moore, S. A., Lee Sweeney, H., Abresch, R. T., Coleman, K. L., Eagle, M., Florence, J., Gappmaier, E., Glanzman, A. M., Henricson, E., Barth, J., Elfring, G. L., Reha, A., Spiegel, R. J., O'Donnell, M. W., Peltz, S. W. & McDonald, C. M. (2014). Ataluren treatment of patients with nonsense mutation dystrophinopathy. Muscle Nerve, 50(4), 477-87. PMID: 25042182.
Bonnemann, C. G., Wang, C. H., Quijano-Roy, S., Deconinck, N., Bertini, E., Ferreiro, A., Muntoni, F., Sewry, C., Beroud, C., Mathews, K. D., Moore, S. A., Bellini, J., Rutkowski, A. & North, K. N. (2014). Diagnostic approach to the congenital muscular dystrophies: consensus on the state of the art. Neuromuscul Disord, 24(4), 289-311.
Moore, S. A., Bossler, A., Brownstein, C. A., Beggs, A. H., Homer, N., Mathews, K. & Margulies, D. M. (2014). An international effort towards developing standards for best practices in analysis, interpretation and reporting of clinical genome sequencing results in the CLARITY challenge. Genome Biol, 15(3), R53. PMID: 24667040.
Wallace, S. E., Conta, J. H., Winder, T. L., Willer, T., Eskuri, J. M., Haas, R., Patterson, K., Campbell, K. P., Moore, S. A. & Gospe, S. M. (2014). A novel missense mutation in POMT1 modulates the severe congenital muscular dystrophy phenotype associated wtih POMT1 nonsense mutations. Neuromuscul Disord, 24, 312-320. PMID: 24491487.
Chauveau, C., Bonnemann, C. G., Julien, C., Ay Lin Kho, A. L., Marks, H., Talim, B., Maury, P., Arne-Bes, M. C., Uro-Coste, E., Alexandrovich, A., Vihola, A., Schäfer, S., Kaufmann, B., Medne, L., Hübner, N., Foley, A. R., Santi, M., Udd, B., Topaloglu, H., Moore, S. A., Gotthardt, M., Samuels, M. E., Gautel, M. & Ferreiro, A. (2014). Homozygous or compound heterozygous truncating mutations of TTN define novel forms of heart disease with congenital myopathy. Hum Mol Genet, 23, 980-991. PMID: 24105469.
Crockett, C. D., Ruggieri, A., Gujrati, M., Zallek, C. M., Ramachandran, N., Minassian, B. A. & Moore, S. A. (2014). Late-adult onset of X-liked myopathy with excessive autophagy (XMEA). Muscle Nerve, 50, 138-144.
Goddeeris, M. M., Wu, B., Venzke, D., Yoshida-Moriguchi, T., Saito, F., Matsumura, K., Moore, S. A. & Campbell, K. P. (2013). LARGE glycans on dystroglycan function as a tunable matrix scaffold to prevent dystrophy. Nature, 503(7474), 136-40. PMID: 24132234.
Khoo, M. K., Hebbar, S. A., Zhao, W., Moore, S. A., Oberley, L. W., Domann, F. E. & Robbins, M. E. (2013). Differential Activation of catalase expression and activity by PPAR agonists: implications for astrocyte protection in anti-glioma therapy. Redox Biology, 1(1), 70-79. PMID: 24024139.
Lin, L. H., Moore, S. A., Jones, S. Y., McGlashon, J. & Talman, W. T. (2013). Astrocytes in the nucleus tractus solitarii are critical for cardiovascualr reflex control. J Neurosci, 33, 18608-18617. PMID: 24259582.
Nguyen, H., Ostendorf, A. P., Satz, J. S., Westra, S., Ross-Barta, S. E., Campbell, K. P. & Moore, S. A. (2013). Glial scaffold required for cerebellar granule cell migration is dependent on dystroglycan function as a receptor for basement membrane proteins. Acta Neuropathol Comms, 1, 58. PMID: 24252195.
Cirak, S., Foley, A. R., Herrmann, R., Willer, T., Yau, S., Stevens, E., Torelli, S., Brodd, L., Kamynina, A., Vondracek, P., Roper, H., Longman, C., Korinthenberg, R., Marrosu, G., Nurnberg, P., Michele, D. E., Plagnol, V., Hurles, M., Moore, S. A., Sewry, C. A., Campbell, K. P., Voit, T. & Muntoni, F. (2013). ISPD Gene Mutations are a common cause of congenital and limb-girdle muscular dystrophies. Brain, 136(Pt 1), 269-81. PMID: 23288328.
Moore, S. A., Gujrati, M., Zallek, C. M., Ramachandran, N. & Minassian, B. (2013). Late-adult onset of X-linked myopathy with excess autophagy (XMEA). (Vols. 72). pp. 586. J Neuropathol Exp Neurol.
Carss, K. J., Stevens, E., Foley, A. R., Cirak, S., Riemersma, M., Torelli, S., Hoischen, A., Willer, T., van Scherpenzeel, M., Moore, S. A., Messina, S., Bertini, E., Bonnemann, C. G., Abdenur, J. E., Grosmann, C. M., Kesari, A., Punetha, J., Quinlivan, R., Waddell, L. B., Young, H. K., Wraige, E., Yau, S., Brodd, L., Feng, L., Sewry, C., MacArthur, D. G., North, K. B., Hoffman, E., Stemple, D., Hurles, M., van Bokhoven, H., Campbell, K. P., Lefeber, D. J., Lin, Y. Y. & Muntoni, F. (2013). Mutations in GDP-mannose pyrophosphorylase B cause congenital and limb girdle muscular dystrophies associated with hypoglycosylation of a-dystroglycan. Am J Hum Genet, 93, 1-13. PMID: 23768512.
Davidson, A. E., Siddiqui, F. M., Lopez, M., Lunt, P., Carlson, H. A., Moore, B. E., Love, S., Roper, H., Born, D. E., Majumdar, A., Jayadev, S., Underhill, H. R., Smith, C. O., von der Hagen, J., Hubner, A., Jardine, P., Merrison, A., Curtis, E., Cullup, T., Jungbluth, H., Cox, M. O., Winder, T. L., Abdel-Salam, H., Li, J. Z., Moore, S. A. & Dowling, J. J. (2013). Novel deletion of lysine 7 expands the clinical, histopathologic and genetic spectrum of TPM2-related myopathies. Brain, 136, 508-521. PMID: 23413262.
McDonald, C. M., Henricson, E. K., Abresch, R. T., Florence, J. M., Eagle, M., Gappmaier, E., Glanzman, A. M., PTC124-GD-007-DMD Study Group,, Spiegel, R., Barth, J., Elfring, G., Reha, A. & Peltz, S. (2013). The 6-minute walk test and other endpoints in Duchenne muscular dystrophy: longitudinal natural history observations over 48 weeks from a multicenter study. Muscle Nerve, 48, 343-56. PMID: 23681930.
Chauveau, C., Julien, C., Marks, H., Foley, R., Kho, A. L., Talim, B., Arne-Bes, M. C., Uro-Coste, E., Maury, P., Vihola, A., Udd, B., Topaloglu, H., Moore, S. A., Gautel, M., Bonnemann, C., Samuels, M. E. & Ferreiro, A. (2012). Tackling giants with next generation sequencing: Homozygous or compound heterozygous truncating mutations of TTN define novel forms of cardiomyopathy with skeletal myopathy. American Society of Medical Genetics.
Dowling, J. J., Davidson, A. E., Lopez, M., Siddiqui, F. M., Lung, P., Li, J. Z., Jungbluth, H., Love, S. & Moore, S. A. (2012). Expanding the clinical and genetic phenotype of TPM2-related myopathies. World Muscle Society.
Nguyen, N., Satz, J. S., Turk, R., Campbell, K. P. & Moore, S. A. (2012). Neuronal alpha-dystroglycan is important for proper GABAA receptor-alpha1 clustering in Purkinje neurons. Society for Neuroscience Meeting.
Tesi Rocha, C., Taylor, M., Chang, T., Reyes, C., Winder, T., Moore, S. A., Bonnemann, C. & Nelson, K. (2012). Novel homozygous stop mutation in alphaB crystalline: expanding the phenotype. World Muscle Society.
Willer, T., Lee, H., Lommel, M., Yoshida-Moriguchi, T., Beltran Valero de Bernabe, D. B., Venzke, D., Cirak, S., Schachter, H., Vajsar, J., Voit, T., Muntoni, F., Strahl, S., Mathews, K., Nelson, S. F., Moore, S. A. & Campbell, K. P. (2012). Patient fibroblast functional complementation studies: a valuable tool in the identification of novel Walker-Warburg syndrome disease genes. World Muscle Society.
Talman, W., Dragon, D. N., Jones, S. Y., Moore, S. A. & Lin, L. H. (2012). Sudden death and myocardial lesions after damage to catecholamine neurons of the nucleus tractus solitarii in rat. Cellular Mol Neurobiol, 32(7), 1119-26. PMID: 22484855.
Acsadi, G., Moore, S. A., Chéron, A., Delalande, O., Bennett, L., Kupsky, W., El-Baba, M., Le Rumeur, E. & Hubert, J. F. (2012). A novel mutation in spectrin-like repeat 1 of dystrophin central domain causes protein misfolding and mild Becker muscular dystrophy. J Biol Chem, 287(22), 18153-62. PMID: 22453924.
Willer, T., Lee, H., Lommel, M., Yoshida-Moriguchi, T., de Bernabe, D. B., Venzke, D., Cirak, S., Schachter, H., Vajsar, J., Voit, T., Muntoni, F., Loder, A. S., Dobyns, W. B., Winder, T. L., Strahl, S., Mathews, K., Nelson, S. F., Moore, S. A. & Campbell, K. P. (2012). ISPD loss-of-function mutations disrupt dystroglycan O-mannosylation and cause Walker-Warburg syndrome. Nature Genetics, 44(5), 575-80. PMID: 22522420.
Dialynas, G., Flannery, K. M., Zirbel, L. N., Nagy, P. L., Mathews, K., Moore, S. A. & Wallrath, L. (2012). LMNA variants cause cytoplasmic distribution of nuclear pore proteins in Drosophila and human muscle. Human Molecular Genetics, 21(7), 1544-56. PMID: 22186027.
Eskuri, J. M., Stanley, C. M., Moore, S. A. & Mathews, K. (2012). Infantile onset CMT2D/dSMA V in monozygotic twins due to a mutation in the anticodon-binding domain of GARS. J Peripheral Nervous System, 17(1), 132-4. PMID: 22462675.
Joiner, M. A., Koval, O. M., Li, J., He, B. J., Allamargot, C., Guo, Z., Luczak, E. D., Hall, D., Fink, B. D., Chen, B., Yang, J., Moore, S. A., Scholz, T., Strack, S., MOHLER, P. J., Sivitz, W. I., Song, L. & Anderson, M. E. (2012). CaMKII determines mitochondrial stress responses in heart. Nature, 491, 269-273. PMID: 23051746.
Myshrall, T. M., Moore, S. A., Ostendorf, A. P., Satz, J. S., Kowalczyk, T., Nguyen, H. T., Daza, R. A., Lau, C., Campbell, K. P. & Hevner, R. F. (2012). Dystroglycan on radial glia end feet is required for pial basement membrane integrity and columnar organization of the developing cerebral cortex. J Neuropathol Exp Neurol, 71, 1047-1063. PMID: 23147502.
McGaughey, S. D., Nelson, T., Cox, M. O. & Moore, S. A. (2012). Evaluation of calpain-3 in patients with limb-girdle muscular dystrophy. (Vols. 71). pp. 574. J Neuropathol Exp Neurol.
Dowling, J. J., Davidson, A. E., Lopez, M., Siddiqui, F. M., Lung, P., Li, J. Z., Jungbluth, H., Love, S. & Moore, S. A. (2012). Expanding the clinical and genetic phenotype of TPM2-related myopathies. (Vols. 22). pp. 821. Neuromusc Disorders.
Martin, S. E., Moore, S. A., bodkin, C. & Hattab, E. M. (2012). Myofibrillar myopathy with large cores: A case report. (Vols. 71). pp. 587. J Neuropathol Exp Neurol.
Moore, S. A., Moore, B. E., Love, S., Li, J. Z., Lopez, M., von der Hagen, M., Hubner, A., Winder, T. L., Cullup, T., Majumdar, A., Abdel-Salam, H., Siddiqui, F. M., Lung, P. & Dowling, J. J. (2012). Novel beta-tropomyosin mutation (TPM2) causes distal core-rod myopathy and trismus-pseudocamptodactyly with nemaline rods. (Vols. 71). pp. 575. J Neuropathol Exp Neurol.
Moore, S. A., Winder, T. L., Nelson, T., Cox, M. O., Reyes, C., Tesi-Rocha, C. & Chang, T. (2012). Novel homozygous stop mutation in alphaB crystallin (CRYAB:p.Ser135*) causes fatal congenital form of myofibillar myopathy. (Vols. 71). pp. 587-588. J Neuropathol Exp Neurol.
Tesi Rocha, C., Taylor, M., Chang, T., Reyes, C., Winder, T., Moore, S. A., Bonnemann, C. & Nelson, K. (2012). Novel homozygous stop mutation in alphaB crystalline: expanding the phenotype. (Vols. 22). pp. 821. Neuromusc Disorders.
Willer, T., Lee, H., Lommel, M., Yoshida-Moriguchi, T., Beltran Valero de Bernabe, D. B., Venzke, D., Cirak, S., Schachter, H., Vajsar, J., Voit, T., Muntoni, F., Strahl, S., Mathews, K., Nelson, S. F., Moore, S. A. & Campbell, K. P. (2012). Patient fibroblast functional complementation studies: a valuable tool in the identification of novel Walker-Warburg syndrome disease genes. (Vols. 22). pp. 805. Neuromusc Disorders.
Di Blasi, C., Bellafiore, E., Salih, M. A., Manzini, M. C., Moore, S. A., Seidahmed, M. Z., Mukhtar, M. M., Karrar, Z. A., Walsh, C. A., Campbell, K. P., Mantegazza, R., Morandi, L. & Mora, M. (2011). Variable disease severity in Saudi Arabian and Sudanese families with c.3924 + 2 T > C mutation of LAMA2. BMC Research Notes, 4(1), 534. PMID: 22166137.
Gundogdu, B. M., Rudnicki, S., Al-Lahham, T., Gokden, M. & Moore, S. A. (2011). A young patient with amyloid deposits in the muscle. Carrell-Krusen Neuromuscular Symposium, Dallas, TX.
Kazmi, S. A., McComb, R. D., Gokden, M., Spuler, S., Filho, J. A., Huston, K. A., Gundogdu, B. & Moore, S. A. (2011). Amyloid myopathy associated with dysferlinopathy: comparison with light chain amyloidosis. (Vols. 70). pp. 524. J Neuropathol Exp Neurol.
Mathews, K., Stephan, C. M., Laubenthal, K., Winder, T. L., Michele, D. E., Moore, S. A. & Campbell, K. P. (2011). Myoglobinuria and muscle pain are common in patients with limb-girdle muscular dystrophy 2I. Neurology, 76(2), 194-5. PMID: 21220724.
Guo, L. T., Moore, S. A., Forcales, S., Engvall, E. & Shelton, G. D. (2010). Evaluation of commercial dysferlin antibodies on canine, mouse and human skeletal muscle. Neuromuscular Disorders, 20(12), 820-5. PMID: 20817457.
Han, R., Frett, E. M., Levy, J. R., Rader, E. P., Lueck, J. D., Bansal, D., Moore, S. A., Ng, R., Beltrán-Valero de Bernabé, D., Faulkner, J. A. & Campbell, K. P. (2010). Genetic ablation of complement C3 attenuates muscle pathology in dysferlin-deficient mice. J Clin Invest, 120(12), 4366-74. PMID: 21060153.
Satz, J. S., Ostendorf, A. P., Hou, S., Turner, A., Kusano, H., Lee, J. C., Turk, R., Nguyen, H., Ross-Barta, S. E., Westra, S., Hoshi, T., Moore, S. A. & Campbell, K. P. (2010). Distinct functions of glial and neuronal dystroglycan in the developing and adult mouse brain. J Neurosci, 30(43), 14560-72. PMID: 20980614.
Mathews, K., Nagan, M. R., Moore, S. A. & Stephan, S. M. (2010). Progressive childhood-onset hearing loss in FSHD. Child Neurology Society annual meeting.
Trantow, C. M., Hedberg-Buenz, A., Iwashita, S., Moore, S. A. & Anderson, M. G. (2010). Elevated oxidative membrane damage associated with genetic modifiers of Lyst-mutant phenotypes. PLoS genetics, 6(7), e1001008. PMID: 20617205.
Margeta, M., Connolly, A. M., Winder, T. L., Pestronk, A. & Moore, S. A. (2009). Cardiac pathology exceeds skeletal muscle pathology in two cases of limb-girdle muscular dystrophy type 2I. Muscle & Nerve, 40(5), 883-9. PMID: 19705481.
Satz, J. S., Philp, A. R., Nguyen, H. M., Kusano, H., Lee, J., Turk, R., Riker, M. J., Hernández, J., Weiss, R. M., Anderson, M. G., Mullins, R. F., Moore, S. A., Stone, E. M. & Campbell, K. P. (2009). Visual impairment in the absence of dystroglycan. J Neurosci, 29(42), 13136-46. PMID: 19846701.
Rodríguez-Lebrón, E., Gouvion, C. M., Moore, S. A., Davidson, B. L. & Paulson, H. L. (2009). Allele-specific RNAi mitigates phenotypic progression in a transgenic model of Alzheimer's disease. Mol Ther, 17(9), 1563-73. PMID: 19532137.
Han, R., Kanagawa, M., Yoshida-Moriguchi, T., Rader, E. P., Ng, R. A., Michele, D. E., Muirhead, D. E., Kunz, S., Moore, S. A., Iannaccone, S. T., Miyake, K., McNeil, P. L., Mayer, U., Oldstone, M. B., Faulkner, J. A. & Campbell, K. P. (2009). Basal lamina strengthens cell membrane integrity via the laminin G domain-binding motif of alpha-dystroglycan. Proc Natl Acad Sci USA, 106(31), 12573-9. PMID: 19633189.
Chang, W., Winder, T. L., LeDuc, C. A., Simpson, L. L., Millar, W. S., Dungan, J., Ginsberg, N., Plaga, S., Moore, S. A. & Chung, W. K. (2009). Founder Fukutin mutation causes Walker-Warburg syndrome in four Ashkenazi Jewish families. Prenat Diagn, 29(6), 560-9. PMID: 19266496.
Puckett, R. L., Moore, S. A., Winder, T. L., Willer, T., Romansky, S. G., Covault, K. K., Campbell, K. P. & Abdenur, J. E. (2009). Further evidence of Fukutin mutations as a cause of childhood onset limb-girdle muscular dystrophy without mental retardation. Neuromusc Dis, 19(5), 352-6. PMID: 19342235.
Nayate, A., Moore, S. A., Weiss, R. M., Taktakishvili, O. M., Lin, L. H. & Talman, W. (2009). Cardiac damage after lesions of the nucleus tractus solitarii. Am J Physiol Regul Integr Comp Physiol, 296(2), R272-9. PMID: 19020288.
Nguyen, H., Ostendorf, A., Satz, J., Campbell, K. P. & Moore, S. A. (2009). Dystroglycan and cerebellar granule neuron development. (Vols. 68). pp. 554-555. J Neuropathol Exp Neurol.
Wakefield, S. E., Dimberg, E. L., Moore, S. A. & Tseng, B. S. (2009). Dystrophinopathy presenting with arrhythmia in an asymptomatic 34-year-old man: a case report. J Med Case Reports, 3, 8625. PMID: 19830234.
Cox, E. M., Darbro, B., Mathews, K., Nagy, P. L., CABUAY, B. M. & Moore, S. A. (2009). Novel LMNA mutation in a North American family with LGMD1B and dilated cardiomyopathy. (Vols. 68). pp. 555. J Neuropathol Exp Neurol.
Mathews, K., Stephan, C. M., Laubenthal, K. S. & Moore, S. A. (2008). Genotype and phenotype analysis of a North American cohort with FKRP mutations: congenital muscular dystrophy 1C (MDC 1C) and limb girdle muscular dystrophy 2I (LGMD 2I). Child Neurology Society Meeting.
Kobayashi, Y. M., Rader, E. P., Crawford, R. W., Iyengar, N. K., Thedens, D. R., Faulkner, J. A., Parikh, S. V., Weiss, R. M., Chamberlain, J. S., Moore, S. A. & Campbell, K. P. (2008). Sarcolemma-localized nNOS is required to maintain activity after mild exercise. Nature, 456(7221), 511-5. PMID: 18953332.
Satz, J. S., Barresi, R., Durbeej, M., Willer, T., Turner, A., Moore, S. A. & Campbell, K. P. (2008). Brain and eye malformations resembling Walker-Warburg syndrome are recapitulated in mice by dystroglycan deletion in the epiblast. J Neurosci, 28(42), 10567-75. PMID: 18923033.
Pace, R. A., Peat, R. A., Baker, N. L., Zamurs, L., Mörgelin, M., Irving, M., Adams, N. E., Bateman, J. F., Mowat, D., Smith, N. J., Lamont, P. J., Moore, S. A., Mathews, K., North, K. N. & Lamandé, S. R. (2008). Collagen VI glycine mutations: perturbed assembly and a spectrum of clinical severity. Ann Neurol, 64(3), 294-303. PMID: 18825676.
Netland, J., Meyerholz, D., Moore, S. A., Cassell, M. & Perlman, S. (2008). Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virology, 82(15), 7264-75. PMID: 18495771.
Kobuke, K., Piccolo, F., Garringer, K. W., Moore, S. A., Sweezer, E., Yang, B. & Campbell, K. P. (2008). A common disease-associated missense mutation in alpha-sarcoglycan fails to cause muscular dystrophy in mice. Hum Mol Genet, 17(9), 1201-13. PMID: 18252746.
Moore, S. A., Lamande, S. R. & Winder, T. L. (2008). Diagnostic Testing for Congenital Muscular Dystrophies in a Cohort of USA Patients. Biology and Disease of Skeletal Muscle Meeting.
Spuler, S., Carl, M., Zabojszcza, J., Straub, V., Bushby, K., Moore, S. A., Bähring, S., Wenzel, K., Vinkemeier, U. & Rocken, C. (2008). Dysferlin-deficient muscular dystrophy features amyloidosis. Ann Neurol, 63(3), 323-8. PMID: 18306167.
Ferraris, S., Clark, S., Garelli, E., Davidzon, G., Moore, S. A., Kardon, R. H., Bienstock, R. J., Longley, M. J., Mancuso, M., Gutiérrez Ríos, P., Hirano, M., Copeland, W. C. & DiMauro, S. (2008). Progressive external ophthalmoplegia and vision and hearing loss in a patient with mutations in POLG2 and OPA1. Arch Neurol, 65(1), 125-31. PMID: 18195150.
Yokoyama, T., Lisi, T. L., Moore, S. A. & Sluka, K. A. (2007). Muscle fatigue increases the probability of developing hyperalgesia in mice. J Pain, 8(9), 692-9. PMID: 17627895.
Winder, T. L., Laffin, J. S. & Moore, S. A. (2007). Common mutations detected for diagnosis of limb-girdle muscular dystrophy. (Vols. 21). pp. A398-399. FASEB J.
McComb, R. D., Radio, S. J., McAllister, J. L., Erickson, C. C., Pattee, G. L. & Moore, S. A. (2007). Danon disease (autophagocytic vacuolar myopathy): clinicopathologic features of a kindred. (Vols. 21). pp. A399. FASEB J.
Fang, X., Faraci, F. M., Kaduce, T. L., Harmon, S., Modrick, M. L., Hu, S., Moore, S. A., Falck, J. R., Weintraub, N. L. & Spector, A. A. (2006). 20-Hydroxyeicosatetraenoic acid is a potent dilator of mouse basilar artery: role of cyclooxygenase. Am J Physiol Heart Circ Physiol, 291(5), H2301-7. PMID: 16782846.
Khalsa, S. S., Moore, S. A. & Van Hoesen, G. W. (2006). Hughlings Jackson and the role of the entorhinal cortex in temporal lobe epilepsy: from patient A to Doctor Z. Epilepsy & Behavior, 9(3), 524-31. PMID: 16942917.
Moore, S. A., Shilling, C. J., Westra, S., Wall, C., Wicklund, M. P., Stolle, C., Brown, C. A., Michele, D. E., Piccolo, F., Winder, T. L., Stence, A., Barresi, R., King, N., King, W., Florence, J., Campbell, K. P., Fenichel, G. M., Stedman, H. H., Kissel, J. T., Griggs, R. C., Pandya, S., Mathews, K., Pestronk, A., Serrano, C., Darvish, D. & Mendell, J. R. (2006). Limb-girdle muscular dystrophy in the United States. J Neuropathol Exp Neurol, 65(10), 995-1003. PMID: 17021404.
Occhi, S., Zambroni, D., Del Carro, U., Amadio, S., Sirkowski, E. E., Scherer, S. S., Campbell, K. P., Moore, S. A., Chen, Z. L., Strickland, S., Di Muzio, A., Uncini, A., Wrabetz, L. & Feltri, M. L. (2005). Both laminin and Schwann cell dystroglycan are necessary for proper clustering of sodium channels at nodes of Ranvier. J Neurosci, 25(41), 9418-27. PMID: 16221851.
Collins, X. H., Harmon, S. D., Kaduce, T. L., Berst, K. B., Fang, X., Moore, S. A., Raju, T. V., Falck, J. R., Weintraub, N. L., Duester, G., Plapp, B. V. & Spector, A. A. (2005). Omega-oxidation of 20-hydroxyeicosatetraenoic acid (20-HETE) in cerebral microvascular smooth muscle and endothelium by alcohol dehydrogenase 4. J Biol Chem, 280(39), 33157-64. PMID: 16081420.
Apostolova, L. G., White, M., Moore, S. A. & Davis, P. (2005). Deep white matter pathologic features in watershed regions: a novel pattern of central nervous system involvement in MELAS. Arch Neurol, 62(7), 1154-6. PMID: 16009776.
Ostendorf, A., Satz, J., Westra, S., Ross-Barta, S. E., Campbell, K. P. & Moore, S. A. (2005). Abnormal cerebral histogenesis following deletion of dystroglycan. (Vols. 64). (64), pp. 446. J Neuropathol Exp Neurol.
Chen, P., Hu, S., Yao, J., Moore, S. A., Spector, A. A. & Fang, X. (2005). Induction of cyclooxygenase-2 by anandamide in cerebral microvascular endothelium. Microvascular Res, 69(2-Jan), 28-35. PMID: 15797258.
Barresi, R., Michele, D. E., Kanagawa, M., Harper, H. A., Dovico, S. A., Satz, J. S., Moore, S. A., Zhang, W., Schachter, H., Dumanski, J. P., Cohn, R. D., Nishino, I. & Campbell, K. P. (2004). LARGE can functionally bypass alpha-dystroglycan glycosylation defects in distinct congenital muscular dystrophies. Nature Medicine, 10(7), 696-703. PMID: 15184894.
Moore, S. A., Ross-Barta, S. E., Westra, S., Saito, F., Messing, A., Bajenaru, M. L., Gutmann, D. & Campbell, K. P. (2004). Cerebellar dysgenesis correlates with the timing and extent of dystroglycan deletion in conditional knockout mice. (Vols. 63). pp. 519. J Neuropathol Exp Neurol.
Moore, S. A., Shilling, C. J., Westra, S., Wicklund, M. P., Brown, C. A., Michele, D. A., Stolle, C. A., Campbell, K. P., Fenichel, G. M., Griggs, R. C., Kissel, J. T., Mathews, K., Pestronk, A., Wal, C. & Mendell, J. R. (2004). Limb-Girdle Muscular Dystrophy in the USA: distribution of immunophenotypes and genotypes from an ongoing multi-center collaborative study. (Vols. 63). pp. 532. J Neuropathol Exp Neurol.
Chen, P., Hu, S., Harmon, S. D., Moore, S. A., Spector, A. A. & Fang, X. (2004). Metabolism of anandamide in cerebral microvascular endothelial cells. Prostaglandins Other Lipid Mediat, 73(2-Jan), 59-72. PMID: 15165032.
Mathews, K., Moore, S. A. (2004). Multiminicore myopathy, central core disease, malignant hyperthermia susceptibility, and RYR1 mutations: one disease with many faces?. Arch Neurol, 61(1), 27-9. PMID: 14732615.
Radhakrishnan, R., Moore, S. A. & Sluka, K. A. (2003). Unilateral carrageenan injection into muscle or joint induces chronic bilateral hyperalgesia in rats. Pain, 104(3), 567-77. PMID: 12927629.
Saito, F., Moore, S. A., Barresi, R., Henry, M. D., Messing, A., Ross-Barta, S. E., Cohn, R. D., Williamson, R. A., Sluka, K. A., Sherman, D. L., Brophy, P., Schmelzer, J. D., Low, P. A., Wrabetz, L., Feltri, M. L. & Campbell, K. P. (2003). Unique role of dystroglycan in peripheral nerve myelination, nodal structure, and sodium channel stabilization. Neuron, 38(5), 747-58. PMID: 12797959.
Mathews, K., Moore, S. A. (2003). Limb Girdle Muscular Dystrophy. (Vols. 3). pp. 78-85. Current Neurology and Neuroscience Reports. PMID: 12507416.
Girnun, G. D., Domann, F. E., Moore, S. A. & Robbins, M. E. (2002). Identification of a functional peroxisome proliferator-activated receptor response element in the rat catalase promoter. Mol Endocrinol, 16(12), 2793-801. PMID: 12456800.
Berg, D. J., Zhang, J., Weinstock, J. V., Ismail, H., Earle, K. A., Alila, H., Pamukcu, R., Moore, S. A. & Lynch, R. G. (2002). Rapid development of colitis in NSAID-treated IL-10-deficient mice. Gastroenterology, 123(5), 1527-42. PMID: 12404228.
Fang, X., Chen, P. & Moore, S. A. (2002). The oxygen radical scavenger pyrrolidine dithiocarbamate enhances interleukin-1beta-induced cyclooxygenase-2 expression in cerebral microvascular smooth muscle cells. Microvascular research, 64(3), 405-13. PMID: 12453435.
Cohn, R. D., Henry, M., Michele, D. E., Barresi, R., Saito, F., Moore, S. A., Flanagan, J. D., Skwarchuk, M. W., Robbins, M. E., Mendell, J. R., Williamson, R. A. & Campbell, K. P. (2002). Disruption of DAG1 in differentiated skeletal muscle reveals a role for dystroglycan in muscle regeneration. Cell, 110(5), 639-48. PMID: 12230980.
Moore, S. A., Saito, F., Chen, J., Michele, D. E., Henry, M., Messing, A., Cohn, R. D., Ross-Barta, S. E., Westra, S., Williamson, R. A., Hoshi, T. & Campbell, K. P. (2002). Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy. Nature, 418(6896), 422-5. PMID: 12140559.
Michele, D. E., Barresi, R., Kanagawa, M., Saito, F., Cohn, R. D., Satz, J. S., Dollar, J., Nishino, I., Kelley, R. I., Somer, H., Straub, V., Mathews, K., Moore, S. A. & Campbell, K. P. (2002). Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies. Nature, 418(6896), 417-22. PMID: 12140558.
Bailey, M. C., Dickerson, L. W., Moore, S. A., Schutte, B. C. & Lamb, F. S. (2002). CFTR/CIC-3 double knockout mice display dramatically increased mortality. FASEB J.
Bilunas, M. H., Moore, S. A. (2002). Cyclooxygenase-2 expression and activity are induced by amyloid-beta 1-42 in brain-derived cells. In K. V. Honn (Eds.) Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation and Related Diseases, vol 5. pp. 93-99. Plenum Publishing Corp., New York, NY, Adv Exp Med Biol.
Moore, S. A., Saito, F., Henry, M. D., Messing, A., Low, P. A., Wrabetz, L., Feltri, L. & Campbell, K. P. (2002). Peripheral neuropathy with folded myelin sheaths in mice lacking Schwann cell dystroglycan. (Vols. 61). pp. 485. J Neuropathol Exp Neurol.
Hindman, B. J., Moore, S. A., Cutkomp, J., Smith, T., Ross-Barta, S. E., Dexter, F. & Brian, J. E. (2001). Brain expression of inducible cyclooxygenase 2 messenger RNA in rats undergoing cardiopulmonary bypass. Anesthesiology, 95(6), 1380-8. PMID: 11748396.
Moore, S. A., Saito, F., Henry, M., Messing, A., Cohn, R. D., Williamson, R. & Campbell, K. P. (2001). Abnormal brain development following selective deletion of dystroglycan. Society for Neuroscience.
Grzybicki, D. M., Liu, Y., Moore, S. A., Brown, H. G., Silverman, J. F., D'Amico, F. & Raab, S. S. (2001). Interobserver variability associated with the MIB-1 labeling index: high levels suggest limited prognostic usefulness for patients with primary brain tumors. Cancer, 92(10), 2720-6. PMID: 11745208.
Williard, D. E., Harmon, S. D., Kaduce, T. L., Preuss, M., Moore, S. A., Robbins, M. E. & Spector, A. A. (2001). Docosahexaenoic acid synthesis from n-3 polyunsaturated fatty acids in differentiated rat brain astrocytes. J Lipid Res, 42(9), 1368-76. PMID: 11518755.
Afifi, A. K., Follett, K. A., Greenlee, J. D., Scott, W. & Moore, S. A. (2001). Optic neuritis: a novel presentation of Schilder's disease. J Child Neurol, 16(9), 693-6. PMID: 11575614.
Chen, Y., Zhang, J., Moore, S. A., Ballas, Z. K., Portanova, J. P., KRIEG, A. M. & Berg, D. J. (2001). CpG DNA induces cyclooxygenase-2 expression and prostaglandin production. Int Immunol, 13(8), 1013-20. PMID: 11470771.
Brian, J. E., Faraci, F. M. & Moore, S. A. (2001). COX-2-dependent delayed dilatation of cerebral arterioles in response to bradykinin. Am J Physiol Heart Circ Physiol, 280(5), H2023-9. PMID: 11299202.
Felice, K. J., Moore, S. A. (2001). Unusual clinical presentations in patients harboring the facioscapulohumeral dystrophy 4q35 deletion. Muscle & nerve, 24(3), 352-6. PMID: 11353419.
Berg, D. J., Zhang, J., Lauricella, D. M. & Moore, S. A. (2001). Il-10 is a central regulator of cyclooxygenase-2 expression and prostaglandin production. J Immunol, 166(4), 2674-80. PMID: 11160331.
Watkins, P. A., Hamilton, J. A., Leaf, A., Spector, A. A., Moore, S. A., Anderson, R. E., Moser, H. W., Noetzel, M. J. & Katz, R. (2001). Brain uptake and utilization of fatty acids: applications to peroxisomal biogenesis diseases. J Mol Neurosci, 16, 87-92. PMID: 11478388.
Katz, R., Hamilton, J. A., Spector, A. A., Moore, S. A., Moser, H. W., Noetzel, M. J. & Watkins, P. A. (2001). Brain uptake and utilization of fatty acids: recommendations for future research. J Mol Neurosci, 16, 333-335. PMID: 11478387.
Berg, D. J., Lynch, R. & Moore, S. A. (2001). IL-10 is a central regulator of cyclooxygenase expression and prostaglandin production. FASEB J.
Piccolo, F., Moore, S. A., Mathews, K. & Campbell, K. P. (2001). Limb-girdle muscular dystrophies. In R. Pourmand , Y. Harati (Eds.) Neuromuscular Disorders. pp. 273-291. Lippencott Williams & Wilkins, Philadelphia. Adv Neurol.
Wickland, M. P., Moore, S. A., Campbell, K. P., Mathews, K., Wall, C., Shilling, C., King, N., King, W., Serrano, C., Kissel, J. T., Fenichel, G. M., Griggs, R. C., Pestronk, A., Stedman, H., Stolle, D. & Mendell, J. R. (2001). Molecular and clinical characterization of individuals with limb-girdle muscular dystrophy. American Academy of Neurology Meeting.
Moore, S. A. (2001). Polyunsaturated fatty acid synthesis and release by brain-derived cells in vitro. J Mol Neurosci, 16, 195-200. PMID: 11478374.
Cohn, R. D., Durbeej, M., Moore, S. A., Coral-Vazquez, R., Prouty, S. & Campbell, K. P. (2001). Prevention of cardiomyopathy in mouse models lacking the smooth muscle sarcoglycan-sarcospan complex. J Clin Invest, 107(2), R1-7. PMID: 11160141.
Williard, D. E., Harmon, S. D., Preuss, M. A., Kaduce, T. L., Moore, S. A. & Spector, A. A. (2001). Production and release of docosahexaenoic acid by differentiated rat brain astrocytes. In T. Hamazaki , H. Okuyama (Eds.) Proceedings of the 4th Congress of ISSFAL, Fatty Acids and Lipids – New Findings. (Vols. 88). pp. 168-172. World Rev Nutr Diet.
Moore, S. A., Saito, F., Henry, M., Messing, A., Cohn, R. D., Williamson, R. & Campbell, K. P. (2001). Selective deletion of brain dystroglycan results in neuronal migration errors. (Vols. 60). pp. 512. J Neuropathol Exp Neurol.
Sluka, K. A., Kalra, A. & Moore, S. A. (2001). Unilateral intramuscular injections of acidic saline produce a bilateral, long-lasting hyperalgesia. Muscle & nerve, 24(1), 37-46. PMID: 11150964.
Barresi, R., Moore, S. A., Stolle, C. A., Mendell, J. R. & Campbell, K. P. (2000). Expression of gamma-sarcoglycan in smooth muscle and its interaction with the smooth muscle sarcoglycan-sarcospan complex. J Biol Chem, 275(49), 38554-60. PMID: 10993904.
Piccolo, F., Moore, S. A., Ford, G. C. & Campbell, K. P. (2000). Intracellular accumulation and reduced sarcolemmal expression of dysferlin in limb--girdle muscular dystrophies. Ann Neurol, 48(6), 902-12. PMID: 11117547.
Fang, X., Moore, S. A., Nwankwo, J. O., Weintraub, L. N., Oberley, W. L., Snyder, D. G. & Spector, A. A. (2000). Induction of cyclooxygenase-2 by overexpression of the human catalase gene in cerebral microvascular endothelial cells. J Neurochem, 75(2), 614-23. PMID: 10899936.
Crosbie, R. H., Lim, L. E., Moore, S. A., Hirano, M., Hays, A. P., Maybaum, S. W., Collin, H., Dovico, S. A., Stolle, C. A., Fardeau, M., Tomé, F. M. & Campbell, K. P. (2000). Molecular and genetic characterization of sarcospan: insights into sarcoglycan-sarcospan interactions. Hum Mol Genetics, 9(13), 2019-27. PMID: 10942431.
Felice, K. J., North, W. A., Moore, S. A. & Mathews, K. (2000). FSH dystrophy 4q35 deletion in patients presenting with facial-sparing scapular myopathy. Neurology, 54(10), 1927-31. PMID: 10822431.
Moore, S. A., Bilunas, M. H. (2000). Amyloid-beta peptide induces cyclooxygenase-2 expression and activity in brain-derived cells. (Vols. 59). pp. 448. J Neuropathol Exp Neurol.
Moore, S. A., Ross-Barta, S., Weydert, J. & Yoder, E. (2000). COX-2 expression in cerebral endothelium: a delayed effect of bradykinin. (Vols. 59). pp. 459. J Neuropathol Exp Neurol.
Durbeej, M., Cohn, R. D., Hrstka, R. F., Moore, S. A., Allamand, V., Davidson, B. L., Williamson, R. A. & Campbell, K. P. (2000). Disruption of the beta-sarcoglycan gene reveals pathogenetic complexity of limb-girdle muscular dystrophy type 2E. Molecular cell, 5(1), 141-51. PMID: 10678176.
Cohn, R. D., Coral, R., Moore, S. A., Hill, J. A., Weiss, R. M., Davisson, R., Straub, V., Bansal, D., Williamson, R. & Campbell, K. P. (1999). Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: a novel mechanism in the pathogenesis of ischemic cardiomyopathy and muscular dystrophy. 72nd Scientific Sessions of the American Heart Association.
Sluka, K. A., kalra, A. & Moore, S. A. (1999). A new model of chronic muscle pain. Society for Neuroscience Meeting.
Hilfers, M. A., Moore, S. A. (1999). Amyloid-beta peptide induces cyclooxygenase-2 expression and activity in brain-derived cells. Society for Neuroscience Meeting.
Coral-Vazquez, R., Cohn, R. D., Moore, S. A., Hill, J. A., Weiss, R. M., Davisson, R. L., Straub, V., Barresi, R., Bansal, D., Hrstka, R. F., Williamson, R. & Campbell, K. P. (1999). Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: a novel mechanism for cardiomyopathy and muscular dystrophy. Cell, 98(4), 465-74. PMID: 10481911.
Moore, S. A., Coral, R., Cohn, R. D., Straub, V., Williamson, R. & Campbell, K. P. (1999). Severe muscular dystrophy and cardiomyopathy in mice deficient in delta-sarcoglycan. 75th Annual Meeting of the American Association of Neuropathologists in Portland, OR.
Girnum, G. D., Domann, F. E., Moore, S. A. & Robbins, M. E. (1999). Nuclear hormone receptors and polyunsaturated fatty acids modulate catalase gene expression. AACR Annual Meeting.
Moore, S. A., Weydert, J., Yoder, E., Faraci, F. M. & Brian Jr, J. E. (1999). Bradykinin induces COX-2 in cerebral endothelium. (Vols. 13). pp. A1072. GASEB j.
Yoder, E. J., Rich, G., Hilfers, M. A., Albright, J. P., Weydert, J. & Moore, S. A. (1999). Cerebrovascular cyclooxygenase-2 (COX-2) is regulated by pro- and anti-inflammatory agents. (Vols. 58). pp. 542. J Neuropathol Exp Neurol.
Brian Jr, J. E., Moore, S. A. & Faraci, F. M. (1999). COX-2 mediated effects of bradykinin in cerebral arterioles. (Vols. 13). pp. A1072. FASEB J.
Girnun, G. D., Moore, S. A., Oberley, L. W. & Robbins, M. E. (1999). Eicosapentaenoic acid alters Mn-SOD levels in normal but not malignant CNS-derived cells. In K. V. Honn , L. J. Marnett , S. Nigam (Eds.) Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation and Related Diseases, vol 4. (Vols. 469). pp. 647-653. Plenum Publishing Corp., New York, NY, Adv Exp Med Biol.
Grzybicki, D. M., Moore, S. A. (1999). Implications of prognostic markers in brain tumors. Clin Lab Med, 19, 833-847.
Moore, S. A., Yoder, E. J., Rich, G., Hilfers, M. & Albright, J. P. (1999). Regulation of cerebrovascular cyclooxygenase-2 by pro- and anti-inflammatory cytokines. In Honn , L. J. Marnett , S. Nigam (Eds.) Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation and Related Diseases, vol 4. pp. 125-130. Plenum Publishing Corp., Adv Exp Med Biol.
Fang, X., Moore, S. A., Stoll, L. L., Rich, G., Kaduce, T. L., Weintraub, N. L. & Spector, A. A. (1998). 14,15-Epoxyeicosatrienoic acid inhibits prostaglandin E2 production in vascular smooth muscle cells. Am J Physiol, 275(6 Pt 2), H2113-21. PMID: 9843811.
Brian, J. E., Moore, S. A. & Faraci, F. M. (1998). Expression and vascular effects of cyclooxygenase-2 in brain. Stroke; a journal of cerebral circulation, 29(12), 2600-6. PMID: 9836773.
Fang, X., Weintraub, N. L., Moore, S. A., Kaduce, T. L. & Spector, A. A. (1998). 14,15-Epoxyeicosatrienoic acid enhances platelet-derived growth factor-induced vascular smooth muscle cell proliferation. 71st Scientific Sessions of the American Heart Association.
Moore, S. A., Yoder, E. J., Campbell, I. & Murphy, S. (1998). Cerebrovascular cyclooxygenase-2 (COX-2) is induced by activated astrocytes. Society for Neuroscience Meeting.
Hilfers, M. A., Moore, S. A. (1998). Cyclooxygenase-2 expression and activity are blunted in nitric oxide synthase-2 null astrocytes. Society for Neuroscience Meeting.
Bohlken, D. P., Alden, B. & Moore, S. A. (1998). Detection of chromosome 4q35 deletion associated with facioscapulohumeral muscular dystrophy (FSHD) by Southern blot analysis. Association for Molecular Pathology Annual Meeting.
Duclos, F., Straub, V., Moore, S. A., Venzke, D. P., Hrstka, R. F., Crosbie, R. H., Durbeej, M., Lebakken, C. S., Ettinger, A. J., van der Meulen, J., Holt, K. H., Lim, L. E., Sanes, J. R., Davidson, B. L., Faulkner, J. A., Williamson, R. & Campbell, K. P. (1998). Progressive muscular dystrophy in alpha-sarcoglycan-deficient mice. J Cell Biol, 142(6), 1461-71. PMID: 9744877.
Rich, G., Yoder, E. J. & Moore, S. A. (1998). Regulation of prostaglandin H synthase-2 expression in cerebromicrovascular smooth muscle by serum and epidermal growth factor. J Cell Physiol, 176(3), 495-505. PMID: 9699502.
Garell, P. C., Menezes, A. H., Baumbach, G. L., Moore, S. A., Nelson, G., Mathews, K. & Afifi, A. K. (1998). Presentation, management and follow-up of Schilder's disease. Pediatr Neurosurg, 29(2), 86-91. PMID: 9792962.
Moore, S. A., Yoder, E. J., Campbell, I. & Murphy, S. (1998). Cerebral endothelial cyclooxygenase-2 (COX-2) is induced by cytokine-activated astrocytes. (Vols. 12). pp. A674. FASEB J.
Bohlken, D. P., Alden, B. & Moore, S. A. (1998). Detection of chromosome 4q35 deletion associated with facioscapulohumeral muscular dystrophy (FSHD) by Southern blot analysis. (Vols. 153). pp. 1650. Am J Pathol.
Spector, A. A., Moore, S. A. & Yorek, M. A. (1998). Docosahexaenoic acid metabolism and function in the central nervous system: studies with cell culture model systems. In R. A. Riemersma , R. Armstrong & T. W. Kelly , R. Wilson (Eds.) Essential Fatty Acids and Eicosanoids: Invited Papers from the Fourth International Congress.. pp. 16-18. AOCS Press, Champaign IL.
Grzybicki, D., Moore, S. A., Schelper, R., Glabinski, A. R., Ransohoff, R. M. & Murphy, S. (1998). Expression of monocyte chemoattractant protein (MCP-1) and nitric oxide synthase-2 following cerebral trauma. Acta neuropathologica, 95(1), 98-103. PMID: 9452827.
Gard, A. L., Pennica, D., Moore, S. A. & Ford, O. (1997). Cardiotrophin-1 induces an astrocyte phenotype in cultured oligodendrocyte progenitors. Society for Neuroscience Meeting.
Moore, S. A., Yoder, E. J. & Rich, G. (1997). Cerebrovascular cyclooxygenase-2 expression is regulated by pro- and anti-inflammatory cytokines. Society for Neuroscience Meeting.
Hilfers, M. A., Moore, S. A. (1997). Docosahexaenoate enhances the TNF? induction of cyclooxygenase-2 in cerebral endothelium. Society for Neuroscience Meeting.
Girnun, G. D., Moore, S. A., Oberley, L. W. & Robbins, M. E. (1997). Eicosapentaenoic acid alters Mn-SOD levels in normal but not malignant CNS-derived cells. 5th International Conference on Eicosanoids & Other Bioactive Lipids in Cancer, Inflammation and Related Diseases.
Moore, S. A., Yoder, E. J., Rich, G. & Albright, J. (1997). Regulation of cerebrovascular cyclooxygenase-2 by pro- and anti-inflammatory cytokines. 5th International Conference on Eicosanoids & Other Bioactive Lipids in Cancer, Inflammation and Related Diseases.
Sawin, P. D., Traynelis, V. C., Rich, G., Smith, B. A., Maves, T. J., Follett, K. A. & Moore, S. A. (1997). Chymopapain-induced reduction of proinflammatory phospholipase A2 activity and amelioration of neuropathic behavioral changes in an in vivo model of acute sciatica. J Neurosurg, 86(6), 998-1006. PMID: 9171179.
Xu, J., Wu, Y., He, L., Yang, Y., Moore, S. A. & Hsu, C. Y. (1997). Regulation of cytokine-induced iNOS expression by a hairpin oligonucleotide in murine cerebral endothelial cells. Biochem Biophys Res Commun, 235(2), 394-7. PMID: 9199204.
Mathews, K., Moore, S. A., Straub, V., Mills, K. & Campbell, K. P. (1997). Immunohistochemical analysis of myodystrophy mouse muscle. American Association of Neurologists.
Menezes, A. H., Garell, C., Baumbach, G. L., Moore, S. A., Afifi, A. & Mathews, K. (1996). Myelinoclastic diffuse sclerosis (Schilder’s disease) presenting a intracranial masses in childhood. Joint Section on Pediatric Neurological Surgery.
Shafer, R., Moore, S. A., Campbell, I. & Murphy, S. (1996). Activated astrocytes induce nitric oxide synthase-2 expression in cerebrovascular endothelial cells. Society for Neuroscience Meeting.
Moore, S. A., Yoder, E. J. & Rich, G. (1996). Cytokines regulate prostaglandin H sythase-2 in cerebral microvascular endothelium. Society for Neuroscience Meeting.
Grzybicki, D., Loihl, A., Kardos, S., Schelper, R., Moore, S. A., Glabinski, A. R., Ransohoff, R. M. & Murphy, S. (1996). Expression of chemokines and nitric oxide synthase-2 following cerebral trauma. Society for Neuroscience Meeting.
Mills, K. A., Moore, S. A., Tresnak, J. & Mathews, K. (1996). Physical mapping around the myodystrophy locus on mouse chromosome 8. 10th International Mouse Genome Conference.
Spector, A. A., Moore, S. A. (1996). Role of docosahexaenoic acid in the brain. Lipid Forum at the Norwegian Academy for Science and Letters - “Interconversion of polyunsaturated fatty acids, and their functions in membranes.”.
Moore, S. A., Yoder, E. J. & Rich, G. (1996). Prostaglandin H synthase expression in cultured cerebral vascular endothelium and smooth muscle. Frontiers in Bioactive Lipids '96 (XVIth Washington International Spring Symposium).
Rich, G., Yoder, E. J., Prokuski, L. & Moore, S. A. (1996). Prostaglandin production in cultured cerebral microvascular smooth muscle is serum dependent. The American journal of physiology, 270(5 Pt 1), C1379-87. PMID: 8967438.
Sawin, P. D., Traynelis, V. C., Rich, G., Smith, B. A., Maves, T. J., Follett, K. A. & Moore, S. A. (1996). Inhibition of phospholipase A2 activity by chymopapain in an in vivo model of acute sciatica.
Moore, S. A., Yoder, E. J. & Rich, G. (1996). Prostaglandin H synthase expression in cultured cerebral endothelium. (Vols. 10). pp. A585. FASEB J.
Rich, G., Yoder, E. J. & Moore, S. A. (1996). Regulation of prostaglandin H synthase-2 expression in cerebral microvascular smooth muscle by serum and EGF. (Vols. 10). pp. A302. FASEB J.
Moore, S. A., Hurt, E., Yoder, E., Sprecher, H. & Spector, A. A. (1995). Docosahexaenoic acid synthesis in human skin fibroblasts involves peroxisomal retroconversion of tetracosahexaenoic acid. J Lipid Res, 36(11), 2433-43. PMID: 8656081.
Rich, G., Prokuski, L. J., Yoder, E. J. & Moore, S. A. (1995). Epidermal growth factor induces prostaglandin H synthase-2 in cerebral microvascular smooth muscle. Society for Neuroscience Meeting.
Simon, J. S., Baum, J. S., Moore, S. A. & Kasson, B. G. (1995). Arginine vasopressin stimulates protein synthesis but not proliferation of cultured vascular endothelial cells. J Cardiovasc Pharmacol, 25(3), 368-75. PMID: 7769800.
Muhonen, M. G., Piper, J. G., Moore, S. A. & Menezes, A. H. (1995). Cervical epidural hematoma secondary to an extradural vascular malformation in an infant: case report. Neurosurgery, 36(3), 585-7; discussion 587-8. PMID: 7753359.
Rich, G., Prokuski, L. J., Yoder, L. J. & Moore, S. A. (1995). Cultured cerebral microvascular smooth muscle express prostaglandin H synthase-2. (Vols. 9). pp. A374. FASEB J.
Yoder, E. J., VanRollins, M. & Moore, S. A. (1995). Epoxyeicosatrienoic acid (EET) metabolism by cerebral endothelium. (Vols. 9). pp. A374. FASEB J.
Slagel, D. D., Goeken, J. A., PLATZ, C. E. & Moore, S. A. (1995). Primary germinoma of the spinal cord: a case report with 28-year follow-up and review of the literature. Acta neuropathologica, 90(6), 657-9. PMID: 8615089.
Moore, S. A., Yoder, L. J. (1995). Prostaglandin H synthase-2 (PGHS-2) is induced in mouse brain following freeze injury. (Vols. 9). pp. A381. FASEB J.
Moore, S. A. (1995). Targeting of omega-3 fatty acids and synthesis of docosahexaenoic acid at the blood-brain barrier. In Proceedings from the Scientific Conference on Omega-3 Fatty Acids in Nutrition, Vascular Biology, and Medicine.. pp. 186-192. American Heart Association Conference Proceedings..
Afifi, A. K., Bell, W. E., Menezes, A. H. & Moore, S. A. (1994). Myelinoclastic diffuse sclerosis (Schilder's disease): report of a case and review of the literature. J Child Neurol, 9(4), 398-403. PMID: 7822732.
Moore, S. A., Ionasescu, V. (1994). Giant axonal neuropathy: A case study suggesting selective neuronal vulnerability. 12th International Congress of Neuropathology.
Murphy, S., Rich, G., Orgren, K. I., Moore, S. A. & Faraci, F. M. (1994). Astrocyte-derived lipoxygenase product evokes endothelium-dependent relaxation of the basilar artery. Journal of neuroscience research, 38(3), 314-8. PMID: 7523688.
Moore, S. A., Hurt, E. F., Yoder, E. J., Gordon, J. A. & Spector, A. A. (1994). Docosahexaenoate synthesis requires peroxisomal fatty acid retroconversion. AHA Scientific Conference on Omega-3 Fatty Acids in Nutrition, Vascular Biology, and Medicine.
Moore, S. A. (1994). Targeting of omega-3 fatty acids and synthesis of docosahexaenoic acid at the blood-brain barrier. AHA Scientific Conference on Omega-3 Fatty Acids in Nutrition, Vascular Biology, and Medicine.
Rich, G., Murphy, S., Orgren, K. I., Faraci, F. M. & Moore, S. A. (1994). Astrocytes release a factor which stimulates endothelial nitric oxide production. (Vols. 8). pp. A28. FASEB J.
Spector, A. A., Gordon, J. A., Moore, S. A. & Kaduce, T. L. (1994). Beta-oxidation of HETEs: a peroxisomal process. In C. Galli , E. Tremoli (Eds.) Fatty Acids and Lipids: Biological Aspects.. pp. 8-15. World Rev Nutr Diet.
Moore, S. A., Ionasescu, V. (1994). Giant axonal neuropathy: A case study suggesting selective neuronal vulnerability. (Vols. 4). pp. 537. Brain Pathol.
Fitzsimmons, K. M., Moore, S. A. (1994). Kuf's disease presenting as spinocerebellar degeneration. (Vols. 4). pp. 456. Brain Pathol.
Moore, S. A. (1994). Local synthesis and targeting of essential fatty acids at the cellular interface between blood and brain - a role for cerebral endothelium and astrocytes in the accretion of CNS docosahexaenoic acid. In C. Galli , E. Tremoli (Eds.) Fatty Acids and Lipids: Biological Aspects. pp. 128-133. World Rev Nutr Diet.
Moore, S. A., Hurt, E. F., Yoder, E., Gordon, J. & Spector, A. A. (1994). Peroxisomal fatty acid retroconversion in the synthesis of docosahexaenoic acid. (Vols. 8). pp. A659. FASEB J.
Moore, S. A., Kirk, J. S. & Ethel, E. (1994). Pharmacologic and RT-PCR characterization of muscarinic receptors in mouse cerebral microvascular smooth muscle. (Vols. 8). pp. A29. FASEB J.
Moore, S. A. (1994). Schwann cell heterogeneity - might it underlie the diversity seen in Schwann cell tumors?. (Vols. 25). pp. 1113. Human Pathol.
Xu, J., Zhang, P. S., Moore, S. A., Hsu, C. Y. & Hogan, E. L. (1993). Bradykinin-stimulated phosphoinositide turnover and prostacyclin production regulated by phorbol ester and calcium in cerebral endothelial cells. pp. 1389. Society for Neuroscience Meeting.
Moore, S. A., Sprecher, H. & Spector, A. A. (1993). Docosahexaenoic acid (22:6?-3) synthesis from 24-carbon precursors in cerebral endothelium. 1st International Congress of the Intern. Soc. for the Study of Fatty Acids and Lipids, Lugano, Switzerland.
Moore, S. A. (1993). Local synthesis and targeting of essential fatty acids at the cellular interface between blood and brain - a role for cerebral endothelium and astrocytes in the accretion of CNS docosahexaenoic acid. 1st International Congress of the International Society for the Study of Fatty Acids and Lipids, Lugano, Switzerland.
Moore, S. A., Sprecher, H. & Spector, A. A. (1993). Synthesis of docosahexaenoic acid (22:6?-3) by astrocytes is independent of ?4-desaturase. 1st International Congress of the Internat. Soc. for the Study of Fatty Acids and Lipids, Lugano, Switzerland,.
Rogers, J. W., Sato, Y., Moore, S. A., Afifi, A., Bell, W. & Menezes, A. H. (1993). Schilder's disease mimicking brain tumor. American Society of Neuroradiology.
Moore, S. A., Hurt, E., Sprecher, H. & Spector, A. A. (1993). Docosahexaenoic acid (22:6??3) synthesis in astrocytes does not require ?4-desaturase activity. American Society for Neurochemistry Meeting.
Simon, J. S., Baum, J. S., Moore, S. A., Johnson, A. K. & Kasson, B. G. (1993). Arginine vasopressin (AVP) stimulates protein synthesis but not cell division in mouse cerebral vascular endothelial and smooth muscle cells. (Vols. 7). pp. A750. FASEB J.
Moore, S. A. (1993). Cerebral endothelium and astrocytes cooperate in supplying docosahexaenoic acid to neurons. In L. R. Drewes , A. L. Betz (Eds.) Frontiers in Cerebral Vascualr Biology: Transport and Its Regulation. pp. 229-233. Adv Exp Med Biol.
Moore, S. A., Hurt, E., Sprecher, H. & Spector, A. A. (1993). Docosahexaenoic acid (22:6?-3) synthesis from ?-3, 24-carbon precursors in cerebral endothelium. (Vols. 7). pp. A383. FASEB J.
Ghoneim, S., Waldschmidt, T. J., Yoder, L., Moore, S. A. & Baumbach, G. L. (1993). Effect of cyclical stretching on cultured rat cerebral vascular smooth muscle cells: a flow cytometric, confocal laser scanning, and transmission electron microscopy study. G. W. Bailey , C. L. Rieder (Eds.) pp. 426-427. Proceedings of the 51st Annual Meeting of the Microscopy Society of America.
Spector, A. A., Moore, S. A., North, L. A., North, J. A., Kaduce, T. L. & Buettner, G. (1993). Effects of omega-3 fatty acids in endothelial cells. In C. A. Drevon , I. Baksaas , H. E. Krokan (Eds.) Omega-3 Fatty Acids: Metabolism and Biological Effects. pp. 173-181. Birkhauser Verlag, Basel, Switzerland.
Spector, A. A., Moore, S. A. (1993). Role of the cerebromicrovascular endothelium and astrocytes in supplying docosahexaenoic acid to the brain. In A. Sinclair , R. Gibson (Eds.) Essential Fatty Acids and Eicosanoids. pp. 100-103. American Oil Chemist's Society Press.
Spector, A. A., Gordon, J. A., Moore, S. A. & Kaduce, T. L. (1993). ?-oxidation of HETEs: a peroxisonal process. 1st International Congress of the International Society for the Study of Fatty Acids and Lipids, Lugano, Switzerland.
Murphy, S., Kardos, S., Moore, S. A., Orgren, K. L. & Faraci, F. M. (1992). Astrocyte modulation of cerebral vessel function via prostanoid and non-prostanoid factors. Society for Neuroscience Meeting.
Spector, A. A., Moore, S. A., North, L. A., North, J. A., Kaduce, T. L. & Buettner, G. R. (1992). Effects of omega-3 fatty acids in endothelial cells. Omega-3 Fatty Acids - Metabolism & Biological Effects, Oslo, Norway.
Spector, A. A., Kaduce, T. L., Gordon, J. A., Moore, S. A. & VanRollins, M. (1992). Metabolic fate of 12-lipoxygenase products. International Conference on the Biochemistry of Lipids, France.
Haddad, S. F., Moore, S. A., Schelper, R. L. & Goeken, J. A. (1992). Smooth muscle can comprise the sarcomatous component of gliosarcomas. J Neuropathol Exp Neurol, 51(5), 493-8. PMID: 1381414.
Haddad, S. F., Moore, S. A., Schelper, R. L. & Goeken, J. A. (1992). Vascular smooth muscle hyperplasia underlies the formation of glomeruloid vascular structures of glioblastoma multiforme. J Neuropathol Exp Neurol, 51(5), 488-92. PMID: 1381413.
Haddad, S. F., Moore, S. A., Menezes, A. H. & VanGilder, J. C. (1992). Ganglioglioma: 13 years of experience. Neurosurgery, 31(2), 171-8. PMID: 1513423.
Moore, S. A. (1992). The role of cerebral endothelium and astrocytes in supplying docosahexaenoic acid (22:6?-3) to neurons. Cerebral Vascular Biology Conference, Duluth, MN.
Henrich, D. E., Gantz, B. J., Moore, S. A. & Schubkegel, A. J. (1992). Undifferentiated small-cell neoplasm of the petrous apex - A case report. Arch Otolaryngol Head Neck Surg, 118(7), 767-70. PMID: 1320897.
Tonner, D., Belding, P., Moore, S. A. & Schlechte, J. A. (1992). Intracranial dissemination of an ACTH secreting pituitary neoplasm--a case report and review of the literature. J Endocrinol Invest, 15(5), 387-91. PMID: 1324266.
Xu, J., Qu, Z. X., Moore, S. A., Hsu, C. Y. & Hogan, E. L. (1992). Receptor-linked hydrolysis of phosphoinositides and production of prostacyclin in cerebral endothelial cells. J Neurochem, 58(5), 1930-5. PMID: 1313855.
Wilke, W., Burgart, L., Robinson, R. A., Haddad, S. & Moore, S. A. (1992). H-Ras mutations in astrocytomas: Correlation with other oncogene abnormalities. International Association of Pathologist's Meeting.
Burgart, L., Robinson, R. A., Haddad, S. & Moore, S. A. (1992). Proliferating cell nuclear antigen (PCNA) expression in astrocytomas: Correlation with oncogenic abnormalities. International Association of Pathologist's Meeting.
Spector, A. A., Moore, S. A. (1992). Role of the cerebromicrovascular endothelium and astrocytes in supplying docosahexaenoic acid to the brain. Third International Congress on Essential Fatty Acids and Eicosanoids, Adelaide, Australia.
Hart, M. N., Fabry, Z., Love-Homan, L., Sadewasser, K. L. & Moore, S. A. (1992). Brain microvascular smooth muscle and endothelial cells produce granulocyte macrophage colony-stimulating factor and support colony formation of granulocyte-macrophage-like cells. Am J Pathol, 141, 421-427.
Giordano, M. J., Mathur, S. N. & Moore, S. A. (1992). Differential metabolism of hydroxyeicosatetraenoic acid isomers by mouse cerebromicrovascular endothelium. J Neurochem, 58(1), 374-82. PMID: 1727444.
Spector, A. A., Moore, S. A., Gordon, E. E., Gordon, J. A. & Kaduce, T. L. (1992). HETEs and endothelial function. In L. Stein , S. Eisenberg , Y. Stein (Eds.) Atherosclerosis IX, Proceedings of the 9th Internatioanl Symposium on Atherosclerosis. pp. 367-370. R&L Creative Communications Ltd, Tel Aviv.
Simon, J. S., Moore, S. A., Johnson, A. K. & Kasson, B. G. (1992). Localization of arginine-vasopressin (AVP) immunoreactivity in vascular compartments and cultured microvascular endothelial and smooth muscle cells. (Vols. 6). pp. A1738. FASEB J.
Gordon, D. L., Biller, J., Moore, S. A. & Rodnitzky, R. (1992). Thalamic ependymoma presenting as recurrent subarachnoid hemorrhage. J Stroke Cerebrovasc Dis, 2, 106-109.
Mueller, D. P., Moore, S. A., Yuh, W. T. & Sato, Y. (1992). The MRI spectrum of medulloblastoma. Clinical Imaging, 16, 250-255. PMID: 1473031.
Moore, S. A., Giordano, M. J., Kim, H. Y., Salem, N. & Spector, A. A. (1991). Brain microvessel 12-hydroxyeicosatetraenoic acid is the (S) enantiomer and is lipoxygenase derived. J Neurochem, 57(3), 922-9. PMID: 1907312.
Moore, S. A., Yoder, E., Murphy, S., Dutton, G. R. & Spector, A. A. (1991). Astrocytes, not neurons, produce docosahexaenoic acid (22:6?-3) and arachidonic acid (20:4?-6). Meeting on Neurobiology of Essential Fatty Acids, a satellite meeting of the 13th Biennial Meeting of the International Society for Neurochemistry.
Moore, S. A., Giordano, M. J., Kim, H. Y., Salem Jr, N. & Spector, A. A. (1991). Brain microvessel 12-hydroxyeicosatetraenoic acid is the (S) enantiomer and is lipoxygenase-derived. 13th Biennial Meeting of the International Society for Neurochemistry.
Yorek, M. A., Stefani, M. R. & Moore, S. A. (1991). Acute and chronic exposure of mouse cerebral microvessel endothelial cells to increased concentrations of glucose and galactose: effect on myo-inositol metabolism, PGE2 synthesis, and Na+/K(+)-ATPase transport activity. Metabolism: clinical and experimental, 40(4), 347-58. PMID: 1849218.
Burgart, L. J., Robinson, R. A., Haddad, S. F. & Moore, S. A. (1991). Oncogene abnormalities in astrocytomas: EGF-R gene alone appears to be more frequently amplified and rearranged compared with other protooncogenes. Modern Pathology, 4(2), 183-6. PMID: 1675468.
Moore, S. A., Yoder, E., Murphy, S., Dutton, G. R. & Spector, A. A. (1991). Astrocytes, not neurons, produce docosahexaenoic acid (22:6 omega-3) and arachidonic acid (20:4 omega-6). J Neurochem, 56(2), 518-24. PMID: 1824862.
Moore, S. A., Giordano, M. J., Kim, H. Y., Salem Jr, N. & Spector, A. A. (1991). Brain microvessel 12-hydroxyeicosatetraenoic acid is the (S) enantiomer and is lipoxygenase-derived. (Vols. 57). pp. S64. J Neurochem.
Spector, A. A., Moore, S. A. (1991). Effects of polyunsaturated fatty acids in endothelial cells. In N. Simionescu , M. Simionescu (Eds.) Endothelial Cell Dysfunction. pp. 507-524. Plenum Publishing Corp, New York NY.
Burgart, L., Robinson, R. A., Haddad, S. & Moore, S. A. (1991). Oncogene abnormalities in astrocytomas: EGF-R gene alone appears to be more frequently amplified and rearranged compared to other protooncogenes. International Association of Pathologists Meeting.
Haddad, S. F., Moore, S. A., Goeken, J. & Schelper, R. L. (1991). Smooth muscle cells can comprise the sarcomatous element of gliosarcomas. (Vols. 50). pp. 291. J Neuropathol Exp Neurol.
Mueller, D. P., Moore, S. A., Yuh, W. T. & Sato, Y. (1991). The MRI spectrum of medulloblastoma. 29th Annual Meeting of the American Society of Neuroradiology.
Yuh, W. T., Turk, J., Mayr, N. A. & Moore, S. A. (1991). Unusual growth and spread of pituitary adenoma: MR and CT findings in four cases. 29th Annual Meeting of the American Society of Neuroradiology.
Haddad, S. F., Menezes, A. H., Vangilder, J. C. & Moore, S. A. (1990). Ganglioglioma: a 13 year review. Pediatric Section of the American Association of Neurological Surgeons.
Giordano, M. J., Moore, S. A. (1990). Prostacyclin synthetase inhibition by metyrapone in cerebromicrovascular endothelium. American Heart Association, 63rd Scientific Sessions.
Giordano, M. J., Moore, S. A. (1990). Metabolism of hydroxyeicosatetraenoic acids (HETES) by mouse brain endothelium. Society for Neuroscience Meeting.
Fabry, Z., Waldschmidt, T. J., Van Dyk, L., Moore, S. A. & Hart, M. N. (1990). Activation of CD4+ lymphocytes by syngeneic brain microvascular smooth muscle cells. J Immunol, 145(4), 1099-104. PMID: 1974273.
Dyken, M., Biller, J., Yuh, W. T., Fincham, R., Moore, S. A. & Justin, E. (1990). Carotid-cavernous sinus thrombosis caused by Aspergillus fumigatus: magnetic resonance imaging with pathologic correlation--a case report. Angiology, 41(8), 652-7. PMID: 2202234.
Moore, S. A., Yoder, E. & Spector, A. A. (1990). Role of the blood-brain barrier in the formation of long-chain omega-3 and omega-6 fatty acids from essential fatty acid precursors. J Neurochem, 55(2), 391-402. PMID: 2115069.
Sahagun, G., Moore, S. A. & Hart, M. N. (1990). Permeability of neutral vs anionic dextrans in cultured brain microvascular endothelium. Am J Physiol, 259(1 Pt 2), H162-6. PMID: 1695819.
Fabry, Z., Waldschmidt, T. J., Moore, S. A. & Hart, M. N. (1990). Antigen presentation by brain microvessel smooth muscle and endothelium. J Neuroimmunol, 28(1), 63-71. PMID: 2111334.
Moore, S. A. (1990). Brain microvessel 12-HETE is lipoxygenase-derived. Annual Meeting of FASEB.
Moore, S. A., Yoder, L., Murphy, S. & Spector, A. A. (1990). Astrocytes, not neurons, produce 22:6?-3 in the brain. American Society for Neurochemistry Meeting.
Moore, S. A. (1990). Brain microvessel 12-HETE is lipoxygenase-derived. (Vols. 4). pp. A1098. FASEB J.
Haddad, S., Robinson, R. A. & Moore, S. A. (1990). DNA flow cytometry is a predictor of survival in astrocytomas. (Vols. 49). pp. 321. J Neuropathol Exp Neurol.
Laszewski, M., Moore, S. A. (1990). Occult invasive pituitary adenoma predisposing to fatal bacterial meningitis. Clin Neuropathol, 9, 101-105.
Ou, Z. X., Xu, J., Moore, S. A., Hsu, C. Y. & Hogan, E. L. (1990). Receptor agonists induced-phosphoinositide (PI) turnover in cultured endothelial cells (ECs) of murine brain. (Vols. 4). pp. A1116. FASEB J.
Loes, D. J., Ryals, T. J., Moore, S. A. & Yuh, W. T. (1990). Recurrent pituitary adenoma presenting as a posterior fossa mass. American Society for Neuroradiology.
VanRybroek, J. J., Moore, S. A. (1990). Sudden death from bilateral choroid plexus vascular malformation hemorrhage - A case report. Clin Neuropathol, 9, 39-45. PMID: 2407402.
Yerram, N. R., Moore, S. A. & Spector, A. A. (1989). Eicosapentaenoic acid metabolism in brain microvessel endothelium: effect on prostaglandin formation. J Lipid Res, 30(11), 1747-57. PMID: 2559136.
Moore, S. A., Figard, P. H., Spector, A. A. & Hart, M. N. (1989). Brain microvessels produce 12-hydroxyeicosatetraenoic acid. J Neurochem, 53(2), 376-82. PMID: 2501450.
Moore, S. A., Prokuski, L. j., Flugum, L. A. & Hart, M. N. (1989). Prostaglandin I2 and E2 production by cultured cerebromicrovascular smooth muscle is dependent upon serum. 65th Annual Meeting of the American Association of Neuropathologists.
Sahagun, G., Moore, S. A., Fabry, Z., Schelper, R. L. & Hart, M. N. (1989). Purification of murine endothelial cell cultures by flow cytometry using fluorescein-labeled griffonia simplicifolia agglutinin. Am J Pathol, 134(6), 1227-32. PMID: 2757116.
Moore, S. A., Yoder, E. & Spector, A. A. (1989). Cerebral endothelia provide essential fatty acids for the brain. Annual Meeting of the American Society for Neurochemistry Meeting.
Moore, S. A., Yoder, E. & Spector, A. A. (1989). Human microvascular endothelium produce arachidonate (20:4?-6), eicosapentaenoate (20:5?-3), and docosahexaenoate (22:6?-3) from essential fatty acid precursors. Annual Meeting of FASEB.
Xu, J., Chao, J., Moore, S. A., Hogan, E. L. & Hsu, C. Y. (1989). Effects of polymorphonuclear cells (PMNs) on the formation of eicosanoids and kinins by a murine endothelial cell (CEC) line. pp. 1026. Society for Neuroscience Abstracts.
Moore, S. A., Figard, P., Spector, A. A. & Hart, M. N. (1989). Eicosanoid production by isolated cerebral microvessels and cultured cerebral endothelium. Ann NY Acad Sci, 559, 471-473.
Moore, S. A., Figard, P., Spector, A. A. & Hart, M. N. (1989). Eicosanoid production by isolated cerebral microvessels and cultured cerebral endothelium. In B. Al , N. G. Bazan (Eds.) Arachidonic Acid Metabolism in the Nervous System - Physiological and Pathological Significance. pp. 471-473. The New York Academy of Sciences, New York NY.
Moore, S. A., Yoder, E. & Spector, A. A. (1989). Human microvascular endothelium produce arachidonate (20:4?-6), eicosapentaenoate (20:5?-3), and docosahexaenoate (22:6?-3) from essential fatty acid precursors. (Vols. 3). pp. A705. FASEB J.
Sandor, M., Fabry, Z., Moore, S. A., Schelper, R., Hart, M. & Lynch, R. (1989). IgG Fc receptor expression on cell lines established from murine brain. (Vols. 3). pp. A1328. FASEB J.
Moore, S. A., Prokuski, L. j., Flugum, L. A. & Hart, M. N. (1989). Prostaglandin I2 and E2 production by cultured cerebromicrovascular smooth muscle is dependent upon serum. (Vols. 38). pp. 320. J Neuropathol Exp Neurol.
Moore, S. A., Prokuski, L. J., Figard, P. H., Spector, A. A. & Hart, M. N. (1988). Murine cerebral microvascular endothelium incorporate and metabolize 12-hydroxyeicosatetraenoic acid. J Cell Physiol, 137(1), 75-85. PMID: 3170659.
Perlman, S., Jacobsen, G. & Moore, S. A. (1988). Regional localization of virus in the central nervous system of mice persistently infected with murine coronavirus JHM. Virology, 166(2), 328-38. PMID: 2845647.
Moore, S. A., Flugum, L. & Spector, A. A. (1988). Cerebromicrovascular endothelium produce 12-HETE. 5th International Symposium on the Biology of Vascular Endothelial Cells.
Moore, S. A., Prokuski, L. J., Figard, P. H., Spector, A. A. & Hart, M. N. (1988). 12-Hydroxyeicosatetraenoic acid (12-HETE) is produced by cerebral microvessels and inhibits prostaglandin production in cerebral endothelium. Annual Meeting of FASEB.
Moore, S. A., Prokuski, L. J., Figard, P. H., Spector, A. A. & Hart, M. N. (1988). 12-Hydroxyeicosatetraenoic acid (12-HETE) is produced by cerebral microvessels and inhibits prostaglandin production in cerebral endothelium. (Vols. 2). pp. A1522. FASEB J.
Sahagun, G., Fabry, Z., Schelper, R. L., Moore, S. A. & Hart, M. N. (1988). Characterization and purification of endothelial cells in culture by flow cytometry using a fluorescent-labeled Griffonia simplicifolia agglutinin-I (GSA) lectin. (Vols. 2). pp. A933. FASEB J.
Sahagun, G., Moore, S. A. & Hart, M. N. (1988). Charge and size effects on transport of sulfated and non-sulfated macromolecules across cultured endothelial monolayers. (Vols. 36). Clin Res.
Moore, S. A., Spector, A. A. & Hart, M. N. (1988). Eicosanoid metabolism in cerebromicrovascular endothelium. Am J Physiol, 254, C37-C44. PMID: 333721.
Moore, S. A., Spector, A. A. & Gordon, J. A. (1988). Hydroxyeicosatetraenoic acids (HETEs). Prog Lipid Res, 27, 271-323. PMID: 3076240.
Schelper, R. L., Moore, S. A. & Hart, M. N. (1988). True reactive microglia lack muscle-pericyte specific ?-actin. (Vols. 47). pp. 362. J Neuropathol Exp Neurol.
Moore, S. A., Spector, A. A. & Hart, M. N. (1987). Cerebral endothelia release prostaglandins in response to thrombin, bradykinin, serotonin and acetylcholine. Annual Meeting of the Society for Neuroscience.
Vinters, H. V., Reave, S., Costello, P., Girvin, J. P. & Moore, S. A. (1987). Isolation and culture of cells derived from human cerebral microvessels. Cell and tissue research, 249(3), 657-67. PMID: 3664609.
Moore, S. A., Spector, A. A. & Hart, M. N. (1987). 12-hydroxyeicosatetraenoic acid is the major metabolite of arachidonic acid in brain microvessels. 63rd Annual Meeting of the American Association of Neuropathologists.
Moore, S. A., Spector, A. A. & Hart, M. N. (1987). Cerebral endothelia produce prostaglandin I2 and E2 in vitro and release them predominantly from their basal surfaces. Biology of Cerebral Endothelium Symposium.
Hart, M. N., Waldschmidt, T. J., Hanley-Hyde, J. M., Moore, S. A., Kemp, J. D. & Schelper, R. L. (1987). Brain microvascular smooth muscle expresses class II antigens. J Immunol, 138(9), 2960-3. PMID: 3471815.
Spencer, S. E., Walker, F. O. & Moore, S. A. (1987). Chorea-amyotrophy with chronic hemolytic anemia: a variant of chorea-amyotrophy with acanthocytosis. Neurology, 37(4), 645-9. PMID: 3561776.
Moore, S. A., Spector, A. A. & Hart, M. N. (1987). Cerebral endothelial eicosanoid production in vitro. 71st Annual Meeting of the Federation of American Societies for Experimental Biology.
Hart, M. N., VanDyk, L. F., Moore, S. A., Shasby, D. & Cancilla, P. A. (1987). Differential opening of the brain endothelial barrier following neutralization of the endothelial luminal anionic charge in vitro. J Neuropathol Exp Neurol, 46(2), 141-53. PMID: 2434625.
Biller, J., Loftus, C. M., Moore, S. A., Schelper, R. L., Danks, K. R. & Cornell, S. H. (1987). Isolated central nervous system angiitis first presenting as spontaneous intracranial hemorrhage. Neurosurgery, 20(2), 310-5. PMID: 3561741.
Moore, S. A., Spector, A. A. & Hart, M. N. (1987). 12-hydroxyeicosatetraenoic acid is the major metabolite of arachidonic acid in brain microvessels. (Vols. 46). pp. 400. J Neuropathol Exp Neurol.
Moore, S. A., Spector, A. A. & Hart, M. N. (1987). Cerebral endothelia produce prostaglandin I2 and E2 in vitro and release them predominantly from their basal surfaces. (Vols. 14). pp. 337. Canadian J Neurol Sci.
Moore, S. A., Spector, A. A. & Hart, M. N. (1987). Cerebral endothelial eicosanoid production in vitro. (Vols. 46). pp. 355. Fed Proc.
Lagreze, H. L., Brooks, B. R., Moore, S. A., Spencer, S. E., Kornguth, S. E., Bridges, A. J., Levine, R. L. & Perlman, S. B. (1987). Familial amyotrophy, neuropathy, chorea and dementia with spherocytosis/elliptocytosis: a new syndrome. (Vols. 37 (Suppl)). pp. 139. Neurol.
Whitters, E., Schelper, R. L., Moore, S. A. & Hart, M. N. (1987). Lectin and anti-alpha-actin staining to monitor purity of endothelium and vascular muscle culture. (Vols. 46). pp. 1230. Fed Proc.
Schelper, R. L., Moore, S. A. & Whitters, E. (1987). True reactive microglia: non-monocytic, non-pericytic cells of the CNS. (Vols. 46). pp. 1321. Fed Proc.
Hart, M. N., Moore, S. A., Van Dyk, L. F. & Roberts, R. (1986). Are tight junctions necessary for blood-brain barrier function?. In Xth International Congress of Neuropathology, Stockholm, Sweden.
Barloon, T. J., Moore, S. A. & Mitros, F. A. (1986). A case of stenotic obstruction of the jejunum secondary to slow-release potassium. Am J Gastroenterol, 81(3), 192-4. PMID: 3953535.
Smoker, W. R., Biller, J., Moore, S. A., Beck, D. W. & Hart, M. N. (1986). Intradural spinal teratoma: report of a case and review of the literture. Am J Neuroradiol, 7(905-910). PMID: 3096113.
Hart, M. N., Tassell, S. K., Sadewasser, K. L., Schelper, R. L. & Moore, S. A. (1985). Autoimmune vasculitis resulting from in vitro immunization of lymphocytes to smooth muscle. The American journal of pathology, 119(3), 448-55. PMID: 4014434.
Hart, M. N., Sadewasser, K. L., Tassell, S. K., Waldschmidt, T. J., Schelper, R. L. & Moore, S. A. (1985). Autoimmune vasculitis, a model. (Vols. 44). pp. 957. Fed Proc.
Moore, S. A., Bohlen, H. G., Miller, B. G. & Evan, A. P. (1985). Cellular and vessel wall morphology of cerebral cortical arterioles after short-term diabetes in adult rats. Blood Vessels, 22, 265-277.
Moore, S. A., Roberts, R., Van Dyk, L. & Hart, M. N. (1985). Cerebral transendothelial electrical resistance in vitro. 61st Annual Meeting of the American Association of Neuropathologists..
Moore, S. A., Roberts, R., Van Dyk, L. & Hart, M. N. (1985). Cerebral transendothelial electrical resistance in vitro. (Vols. 44). pp. 340. J Neuropath Exp Neurol.
Moore, S. A., Schelper, R. L., Hart, M. N., Robinson, R. A. & Whitters, E. (1985). Glomeruloid hyperplasia in glioblastoma: origin from smooth muscle cells. 62nd Annual Meeting of the American Association of Neuropathologists..
Moore, S. A., Schelper, R. L., Hart, M. N., Robinson, R. A. & Whitters, E. (1985). Glomeruloid hyperplasia in glioblastoma: origin from smooth muscle cells. (Vols. 45). pp. 327. J Neuropathol Exp Neurol.
Vinters, H. V., Reave, S., Costello, P., Girvin, J. P. & Moore, S. A. (1985). Isolation and culture of cells derived from human cerebral microvessels. (Vols. 44). pp. 338. J Neuropathol Exp Neurol.
Schelper, R. L., Hart, M. N., Moore, S. A. & Whitters, E. (1985). True reactive microglia produced by injury to central neuronal processes. (Vols. 45). pp. 345. J Neuropathol Exp Neurol.
Moore, S. A., Strauch, A. R., Yoder, E. J., Rubenstein, P. & Hart, M. N. (1984). Cerebral microvascular smooth muscle in tissue culture. In vitro, 20(6), 512-20. PMID: 6235174.
Beck, D. W., Vinters, H. V., Moore, S. A., Hart, M. N., Henn, F. A. & Cancilla, P. A. (1984). Demonstration of adenosine receptors on mouse cerebral smooth muscle membranes. Stroke, 15(725-727). PMID: 6087502.
Robinson, R. A., Moore, S. A. & Hart, M. N. (1984). Growth control of cerebral microvessel derived smooth muscle cells. (Vols. 8A). pp. 255. J Cellular Biochem Suppl.
Beck, D. W., Vinters, H. V., Moore, S. A., Hart, M. N. & Cancilla, P. A. (1983). Uptake of adenosine by cultured cerebral vascular smooth muscle cells. Journal of neurochemistry, 41(4), 939-41. PMID: 6619860.
Westfall, S. G., Felten, D. L., Mandelbaum, J. A., Moore, S. A. & Peterson, R. G. (1983). Degenerative neuropathy in insulin-treated diabetic rats. Journal of the neurological sciences, 61(1), 93-107. PMID: 6355399.
Moore, S. A., Miller, B., Bohlen, H. & Evan, A. (1983). Scanning and transmission electron microscopic study of cerebral vascular smooth muscle in normal and in diabetic rats. 67th Annual Meeting of the Federation of American Societies for Experimental Biology.
Moore, S. A., Miller, B., Bohlen, H. & Evan, A. (1983). Scanning and transmission electron microscopic study of cerebral vascular smooth muscle in normal and in diabetic rats. 67th Annual Meeting of the Federation of American Societies for Experimental Biology.
Moore, S. A., Yoder, E., Strauch, A., Rubenstein, P. & Hart, M. N. (1983). Isolation and characterization of mouse cerebral vascular smooth muscle in tissue culture. Eighth International Joint Conference on Stroke and Cerebral Circulation.
Beck, D. W., Vinters, H. V., Hart, M. N., Henn, F. A., Moore, S. A. & Cancilla, P. A. (1983). Adenosine and cerebral smooth muscle: uptake and binding. (Vols. 42). pp. 484. Fed Proc.
Moore, S. A., Yoder, E., Strauch, A., Rubenstein, P. & Hart, M. N. (1983). Isolation and characterization of mouse cerebral vascular smooth muscle in tissue culture. (Vols. 14). pp. 131. Stroke.
Moore, S. A., Miller, B., Bohlen, H. & Evan, A. (1983). Scanning and transmission electron microscopic study of cerebral vascular smooth muscle in normal and in diabetic rats. (Vols. 42). pp. 485. Fed Proc.
Rhodes, G., Holland, M. L., Wiesler, D., Novotný, M., Moore, S. A., Peterson, R. G. & Felten, D. L. (1982). Excretion of urinary volatile metabolites in response to alloxan induced diabetes of short duration in rats. Journal of chromatography, 228, 33-42. PMID: 7076757.
Moore, S. A., Peterson, R. G., Felten, D. L. & O'Connor, B. L. (1982). Ultrastructural axonal pathology in experimentally diabetic and aging control rats. Brain research bulletin, 8(3), 317-23. PMID: 7093738.
Rhodes, G., Holland, M. L., Wiesler, D., Novotny, M., Moore, S. A., Peterson, R. G. & Felten, D. L. (1982). Structural relationships between the endogenous volatile urinary metabolites of experimentally diabetic rats and certain neurotoxins (l). Experientia, 38(1), 75-7. PMID: 7056362.
Baughman, S., Felten, S. Y., Lee, W., Moore, S. A., O'Connor, B. L. & Peterson, R. G. (1981). The effect of diabetes on leucine and fucose incorporation into PNS myelin proteins. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme, 13(6), 331-5. PMID: 7262834.
Moore, S. A., Peterson, R. G., Felten, D. L. & O'Connor, B. L. (1981). Glycogen accumulation in tibial nerves of experimentally diabetic and aging control rats. J Neurol Sci, 52, 289-303. PMID: 7310436.
Moore, S. A., Peterson, R. G., Felten, D. L., Cartwright, T. R. & O'Connor, B. L. (1980). Reduced sensory and motor conduction velocity in 25-week-old diabetic [C57BL/Ks (db/db)] mice. Experimental neurology, 70(3), 548-55. PMID: 7439292.
Moore, S. A., Peterson, R. G., Felten, D. L. & O'Connor, B. L. (1980). A quantitative comparison of motor and sensory conduction velocities in short- and long-term streptozotocin- and alloxan-diabetic rats. Journal of the neurological sciences, 48(1), 133-52. PMID: 6448276.
Moore, S. A., O'Connor, B. L., Felten, D. L. & Peterson, R. G. (1980). Ultrastructural changes in tibial nerves of two month streptozotocin and alloxan diabetic rats. Am. Assoc. of Neuropathologists Meeting.
Moore, S. A., Cartwright, T. R., O'Connor, B. L., Felten, D. L. & Peterson, R. G. (1980). Motor and sensory conduction velocity study in the genetically diabetic (db/db) mouse. Midwest Student Medical Research Forum.
Moore, S. A., Cartwright, T. R., O'Connor, B. L., Felten, D. L. & Peterson, R. G. (1980). Motor and sensory conduction velocity study in the genetically diabetic (db/db) mouse. (Vols. 28). pp. 801A. Clin Res.
Cartwright, T. R., Moore, S. A., O'Connor, B. L., Felten, D. L. & Peterson, R. G. (1980). Peripheral neuropathy in diabetic (db/db) mice. (Vols. 28). pp. 797A. Clin Res.
Smith, S. L., Novotny, M., Moore, S. A. & Felton, D. L. (1980). Studies of hyperlipidemia in drug-induced diabetic rats by high-performance liquid chromatography. J Chrom Biomed Appl, 221, 19-26.
Felten, S. Y., Baughman, S., Lee, W., Moore, S. A. & Peterson, R. G. (1980). The effect of diabetes on glycoprotein incorporation into PNS myelin. (Vols. 11). pp. 215. Trans Amer Soc Neurochem.
Moore, S. A., O'Connor, B. L., Felten, D. L. & Peterson, R. G. (1980). Ultrastructural changes in tibial nerves of two month streptozotocin and alloxan diabetic rats. (Vols. 39). pp. 377. J Neruopathol Exp Neurol.
Moore, S. A., Peterson, R. G., Felten, D. L. & O'Connor, B. L. (1979). Early segmental demyelination in experimental diabetic neuropathy. (Vols. 5). pp. 515. Neuroscience Abstracts.
Moore, S. A., Peterson, R. G., Felten, D. L. & O'Connor, B. L. (1979). Early segmental demyelination in experimental diabetic neuropathy. Society for Neuroscience Meetings.
Moore, S. A., O'Connor, B. L., Felten, D. L. & Peterson, R. G. (1979). Experimental diabetic neuropathy - (Dealing with preliminary conduction velocity findings). (Vols. 28). pp. 415. Diabetes.
Moore, S. A., O'Connor, B. L. & Peterson, R. G. (1979). Experimental diabetic neuropathy - (Dealing with preliminary electron microscopic findings). American Association of Anatomists Meeting.
Moore, S. A., O'Connor, B. L. & Peterson, R. G. (1979). Experimental diabetic neuropathy - (Dealing with preliminary electron microscopic findings). (Vols. 193). pp. 627. Anat Rec.